Stereoselective synthesis of 5-substituted pyrrolo[1,2-c]imidazol-3-ones. Access to aldosterone synthase inhibitors and chiral precatalysts by Xu, Shufen
Stereoselective Synthesis of 5-Substituted Pyrrolo[1,2-c]imidazol-3-ones. Access to 
Aldosterone Synthase Inhibitors and Chiral Precatalysts 
Shufen Xu, RSc., Brock University 
M.Sc. Biotechnology 
Submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science 
Faculty of Mathematics and Science, Brock University 
St. Catharines, Ontario 
©2010 
Abstract 
Compounds containing the pyrrolidine moiety are key substructures of 
compounds with biological activity and organocatalysts. In particular, annulated 
chiral pyrrolidines with alpha stereogenic centers have aldostereone synthase 
inhibition activity. In addition, 5-substituted pyrroloimidazol(in)ium salts precursors 
to N-heterocyclic carbene (NHC) precatalysts are rare due to a lack of convenient 
synthetic routes to access them. 
In this thesis is described a rapid synthesis of NHC precursors and a possible 
route to 5-substituted pyrroloimidazole biologically active compounds. The method 
involves the preparation of chiral saturated and achiral unsaturated pyrrolo[I,2-
c]imidazol-3-ones from N-Cbz-protected t-Butyl proline carboxamide. The resulting 
starting materials may be used to prepare the target chiral annulated imidazol(in)ium 
products by a two-step sequence involving first stereoselective lithiation-substitution, 
followed by POCh induced salt formation. 
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1. Introduction: 
Pyrrolidines are a common structural motif found in natural products and biologically 
active molecules, including opioid receptor ligands, natural amino acids, and chiral 
pyrroloimidazoles. l This structural motif has also captured the interest of many organic 
chemists. Besides serving as crucial reagents or reactants in many organic reactions, 
pyrrolidine-containing molecules have been established as important to catalysis and 
asymmetric reactions, wherein selective induction of chirality may be observed. l The 
following section will briefly introduce pyrrolidine-containing biologically active 
molecules, naturally occurring molecules, and chiral reagents. 
1.1 The Pyrrolidine Moiety in Natural Products and Biologically Active Compounds 
A commonly encountered pyrrolidine in nature is the natural amino acid L-proline 1. 
Being the only heterocyclic amino acid in nature, L-proline plays a very important role in 
the secondary structures of proteins. Due to its cyclic structure, proline is commonly 
observed in a given protein where a p-turn is located, which contributes to the rigidity of 
the protein, and in turn can affect biological activities of enzymes?,3,4 The discovery of 
polyproline II helices as the dominant motif in proline-rich sequences has led to rapid 
research in analogues of proline.2 It is believed that the PPII helices plays an important 
role in protein-protein interactions by altering conformations through incorporation of 
analogues of proline (usually by solid phase chemistry), which may affect the bioactivity 
of the protein.25 
1 
~O 
H OH 
1 
Figure 1. L-Proline 
Many 2,5-disubstituted pyrrolidine compounds have been extracted from plants, 
animals and microorganisms. Unfortunately, the quantities isolated are usually very 
limited, thus the biological activity and mechanisms of action of many of these 
compounds have not been studied. 1 Of the molecules studied, some have displayed 
interesting properties such as the ability to inhibit acetylcholinesterase (2),6 and the 
ability to ligate with the opioid receptor (3).1 Another famous pyrrolidine compound is a 
molecule that is inhaled by smokers, nicotine (4). 
Q 
6
1 
71 
~ CI 
3 
CI 
an opioid receptor ligand 
venom in ants 
2 
r0Q ~ .. ) -7-
N 
nicotine 
4 
Figure 2. Examples of pyrrolidine-containing biologically active compounds 
Chiral a-arylated pyrrolidine molecules fused with imidazole (5, 6) are also reported 
In the literature and have been recognized for their inhibitory activities against 
aldosterone synthase and aromatase.7 Thus, they may be utilized to treat disorders or 
disease associated with these two enzymes (e.g., hypokalemia, hypertension, congesitive 
2 
heart failure, and arial fibrillation or renal failure).8 However, these potential drugs were 
synthesized only as racemates and require chiral stationary phase HPLC separation. 
R ~~'"'I/ \ 
R N0N 
R R / 
'':ZR 
R R 5 6 
Figure 3. Chiral pyrroloimidazoles 
1.2 Catalysts Containing the Pyrrolidine Structural Motif 
1.2.a. Guanidines 
Synthetic guanidine analogues are considered to be environmentally friendly catalysts 
since this functional group is widely observed in biological systems.9 Due to their 
resonance within the three nitrogens, the guanidine functionality is generally considered 
to be one of the strongest organic bases (pKa of 12.5).9 This property should allow 
~ {;. 
guanidines to catalyze base-mediated organic reactions. Unfortunately, their application 
in catalysis is not well studied due to the lack of synthetic methods to prepare them which 
may be due to safety issues associated with their synthesis. In the classic method, 
preparation usually involves the use of cyanide reagents, which are extremely toxic, 
dangerous and not environmentally friendly.lO 
A prominent researcher in this field, Ishikawa, has prepared guanidines which 
incorporate a fused pyrroloimidazoline structural motif, prepared by nucleophilic addition 
of an amine to an imidazolinium intermediateY-14 Their activities and applications were 
3 
explored in varIOUS reactions, such as the Michael addition and the 
trimethylsilylcynanation of carbonyl compounds, 15 in which they were proven to be 
effective. 16 
In the asymmetric trimethylsilylcyanation of carbonyl groups, guanidines similar to 8 
have catalyzed this reaction in over 90% yield with low to moderate enantiomeric excess 
(ee). One of the best results was with guanidine 8 in the reaction with 
cyclohexylaldehyde 7 to give 9 in 93% yield and 70% ee. 15 
7 
TMSCN, CH2CI2 
Ph 
H_N)j'''Ph 
)-( 
PIl Ph 
8 
OTMS 
~CN 
-V 
9 
(93% yield, 70% ee) 
Scheme 1. Asymmetric trimethylsilylcyanation of carbonyl compounds15 
(; 
Among other successful applications, guanidines 11-14 have been employed in the 
construction of the chiral backbone of vitamin E (15), involving a 2,2-disubstituted 
chromane skeleton 15. From Scheme 2 and Table 1, the best results were achieved using 
12 to give 15 in 80% ee at 0 °C (but only with 41 % yield). With guanidines 13 and 14, 
there were low enantioselectivities and yields. 16 
4 
C~ 0.2 equivguanidine (11-14) cc:xn I • I OMe // OH 0 OMert, CHCI3 . // 0 
o 
10 15 
Bn Bn 
N~OH N~OH 
)l )l 
MeN NMe MeN NMe 
< ~ ()d ~ ) 
12 13 
~n 
N~OH 
)l 
BnN NBn 
>--{ 
Ptl Ph 
14 
Scheme 2. Guanidines in Michael addition16 
The alcohol function of guanidines 11-14 provides better enantio-induction as 
described by Ishikawa et al. In their speculation, the transition state 16 between guanidine 
and substrate not only allows for hydrogen bonding between the alcohol of the guanidine 
to that of carbonyl of the substrate, but also allows for hydrogen bonding between the 
substrate's phenol and the guanidine nitrogen. This model invokes a I5-membered 
transition state that allows the substrate to avoid a methyl group on the guanidine 
nitrogen, resulting in a preferential attack of only one face of the substrate (Figure 4).16 
5 
OMe 
Me~2""'H_03-~ H 
~D ~ ~ I 
TS 
(re-face attack) 
16 
Figure 4. Transition-state for guanidine 1616 
1.l.b. Chiral Phosphites and Phosphorodiamidites 
Chiral monodentate phosphites and phosphorodiamidites are a relatively new class of 
ligands in transition metal catalysis. 17-19 Ligands such as BINOL derived 17 are very 
useful in applications such as Rh-catalyzed hydrogenation of prochiral unsaturated 
substrates, or Cu-catalyzed conjugate additions of organometallic reagent§ to enones. By 
replacing the BINOL moiety with relatively inexpensive groups, such as biaryl 
bisphenols, comparable enantioselectivities have been achieved. 19 
X=OR, NR2 
17 
QUIPHOS 
18 
19: R = OMe 
20: R = Ot-Bu 
21 :R= r1l 
-~-OtJd 
Figure 5. Examples of chiral phosphites and phosphorodiamidites19 
6 
In 2004, Tsarev and Lyubimov introduced a senes of mono dentate 
phosphorodiamidites with P-stereogenic atoms. According to early publications, such 
stereogenic centers led to good stereo selectivities in some transformations.2o These chiral 
ligands contain pyrrolidine-dervied diamine backbones rather than the well-known 
BINOL moiety, and the reactivities of both the new system and the BINOL system were 
screened in Pd-catalyzed allylic substitution reactions of 1,3-diphenylallyl acetate 22 
(Scheme 3).19 
22 23 
Scheme 3. Allylic substitution reaction with 1,3-diphenylallyl acetate19 
Table 2. Results from Pd-catalyzed allylic substitution reactions of 1,3-diphenylallyl 
acetate (22) using 17_21 19 fr· 
ligand y- Pd(II) source yield (%) ee (%) (conjig) 
19 NaS02PTol Pd(allyl)a 44 97 (S) 
17 NaS02PTol Pd(allyl)CI2 21 72 (R) 
20 PhCH2NH2 Pd(allyl)CI2 76 95 (R) 
17 PhCH2NH2 Pd(allyl)CI2 32 36 (R) 
21 CH2(C02Meh Pd(allyl)CI2 98 97 (S) 
17 CH2(C02Meh Pd(allyl)CI2 8 9 (S) 
18 CH2(C02Meh Pd(allyl)CI2 85 
a Generated in situ. 
7 
The results obtained indicate that catalysts 19-21 give higher enantioselectivities than 
BINOL derived ligands21 by 12% ee. For allylic sulfonation, 19 gave 25% ee better 
selectivity than 17. Ligand 20 gave 95% ee in allylic amination, but ligand 17 provided 
the same product in 36% ee. Finally, in allylic alkylation, 21 provided significantly 
higher yields than those obtained with 17 and QUIPHOS 18 (9% and 85% ee, 
respectively). 19 
1.2.c. N-Heterocyclic Carbenes (NHCs) 
N-Heterocyclic carbenes (NHCs) are unusually stable single carbenes that are also 
sometimes insensitive to air.22 They can be generated by deprotonation of azolium salts in 
THF. Since the mid-1990's, these compounds have been heavily investigated in 
asymmetric catalysis.23,24 Significant reactions include the benzoin condensation and the 
Stetter reaction. Both of these reactions allow for the formation of a new carbon-carbon 
bond, with control of absolute stereochemistry. 
The first enantioselectivity observed in the benzoin condensation was originally 
reported by Sheehan,25 using a thiazolium catalyst in 1966. However, a low value of 26% 
optical purity was obtained. Over the years, increased selectivities were obtained in the 
benzoin condensation (Scheme 4). Particularly noteworthy are the triazolium salts that 
were prepared by Enders and Teles, which demonstrated exceptional selectivities (up to 
99% ee).26 These results were achieved by Enders in 2002 ultilizing a bicylic triazolium 
precatalyst 25.27 This catalyst generated adduct 26 from benzaldehyde in 90% ee 
employing a 10 mol% catalyst and KOt-Bu as base. Reducing the catalyst loading to 2.5 
8 
mol% led to a significant decrease in yield by 50%, but a slight improvement III 
enantiomeric excess (99% ee). 27,28 
0 10 mol % cat 25, 0 ~~N Ph~Ar PhJlH • N I(£) KOt-Bu, ~N, OH 8 BF4 Ph 24 THF, 16 h 26 
(83%) (90% ee) 25 
Scheme 4. Benzoin condensation catalyzed by 25 
Precatalysts 25 not only induced high enantioselectivities in the benzoin 
condensation, but was also employed in the Stetter reaction by Enders27,28 Rovis et al. 
manipulated the electronics of these catalysts and designed two families of new 
triazolium precursors, one of which is the pyrrolo-fused triazolium salt 28, and the other 
of which is morpholine-derived 27?9,30 
b:~~~r X 8 ~ ~ 
morpholine-derived 
27 
pyrrolidine-derived 
28 
Figure 6. Triazolium precatalysts developed by Rovis et al. 
Following the applications of both precatalysts in several Stetter reactions, the 
morpho line derived precatalysts were shown to afford higher enantioselectivities than the 
pyrrolo-fused versions in most of the reactions.29,31 However, the opposite trend was 
observed in the intramolecular cyc1ization of aliphatic aldehydes 29 (Scheme 5) to give 
9 
cyc1opentanones 32, for which 31 afforded the product in 90% ee versus 65% ee using 
o 
C02Me • ~ 20 mol% cat, 20% KHMDS ::::,.... C02Me Ph Me, 25° C 
29 
6'''~~~r ---= e ~ // BF4 
30 31 
78% yield, 65% ee 86% yield, 90% ee 
Scheme 5. Cyc1ization of29 to 32.29,32 
On the other hand, Bode et al. noted earlier that there are few examples of highly 
enantioselective reaction catalyzed by chiral imidzolium-derived NHCs due to difficulties 
in their preparation. To draw a direct comparison of the reactivities of similar chiral 
triazolium and imidazolium precatalysts,33 two almost identical reagents (33 and 34, 
6· 
Scheme 6) had to be synthesized. Notably, imidazolium 33 required an 8-step synthesis 
starting from a chiral syn-l,2-aminoalcoho1.34 Nonetheless, employment of precatalysts 
33 and 34 in the formation of37 resulted in better yield using 33 (34% versus 10%) but 
slightly lower enantioselectivity (85 versus 92% ee).34 
10 
A crotyl bromide I HC02Et t I NH2 NH2 H NH 
c» NaH, DMF c» AcOH THF cO-'::::: .. '::::: '.. '::::: I OH 0 °C, 2 h I ° 62°C 16 h I ° h- h-' h-(67%) (87%) 
NaH. H-J<: or-
DMF cO-> 
- I ~ ° o °C, 2 h //
(56%) (97%) 
° ° ° OAc 
Dess-Martin, H-,< t AC20, HCI04 CIO<t <±>~~ 
CH2CI2 ~ O°Ctort ~ . 
--3 -h,-rt---- 0-J0 --2-h--""· 0-J0 
B 
(88 %) 
MesNH2 A AC20, HCI04 ~ Toluene CICH2CH2CI .. .. e~ CH2CI2 70°C, 6 h eX; rt, 12 h CI04 \\ (51 % over 3 steps) CI04 \\ I <±>N <±>N , 
WO cO-0 
° Ph~H 
35 
33·CI04 
34 
° __ 1_0_m_O_I%_C_a_t'~ __ h fi!.O,,, f Ph 
+ ~ 10 mol% DBU, ~ 
Ph ~ -;:;;.- Ph CICH2CH2CI, 
360°C to rt, 18 h Ph Ph 
37 
Scheme 6. A: Synthesis of 33'C1C04; B: Spirocyclopentanone-forming annulation 
catalyzed by 35 and 3634 
11 
In addition, precatalysts 33 and 34 led to products 40 or 41, respectively; both were 
produced in 99% ee (Scheme 7).35 The counter ion was shown to be important in these 
transformations in that the perchlorate of 33 was ideal for the formation of 40, whereas 
the chloride salt of34 was ideal for the formation of 41. 
o 
R~H 10 mol% 33·CI04 
38 DBU (1 equiv) 
+ 
'-....~Jl/ Ph Me ~ ~ '1 OH 10 mol% 34·CI 
39 
41,99% ee 
Scheme 7. Enantioselective lactone synthesis using precatalysts 33 and 3435 
The difference in reactivity between otherwise identical imidazolium and triazolium-
derived N-heterocyclic carbenes depends on the leaving group ability in acyl azolium 
r:; 
species 42, 43 involved in the lactone formation. Due to the nature of carbenes, it was 
postulated that the triazolium carbene is a better leaving group which provides the p-
lactone 41 as the major product. However, in the case of the imidazolium species, 
elimination of alkoxide occurred in 44 which underwent a retro-aldol-aldol sequence to 
form the y-Iactone 40 (Scheme 8).35 
12 
Ph 
42: Y= N 
! 
o ~~QOH - -
C02Et 
41 
143: Y = C-CH3 
11 
o 
c-!li O~O~ \Yo:-~ 0 N~ . . OH ~NCB J-r 
Ph .--' Mes retro-aldol- • Ph'" Y b;\oe aldol- C02Et . OH lactonization 40 Et02C 
44 
Scheme 8. The possible transformation of 42 to 40 and 4135 
This fascinating enantiodivergent reactivity between triazolium and imidazolium 
precatalyst encouraged us to design an alternate route to chiral imidazol(in)ylidene 
catalysts (vide infra).36 
1.2.d. Proline-derived Diamines in the Aldol Reaction 
Yamamoto et al has described the use of diamines 49-56 in the asymmetric direct 
aldol reaction.37 These diamines contained a pyrrolidine backbone with chiral center(s). 
The selectivities produced from the aldol reaction between acetone and p-
nitro benzaldehyde varied according to diamine. The best results associated with these 
proline-derived diamines were obtained with TfOH salts of diamine 49, which led to 47 
in 60% yield and 88% ee.38 
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Scheme 9: Library of diamines screened for aldol reactions between acetone and 4-
nitrobenzaldehyde38 
1.3. Synthetic Approaches to Chiral Pyrrolidine Derivatives 
The importance of the pyrrolidine functionality in natural products and catalysts has 
sparked the development of stereoselective synthetic methods to prepare these 
compounds. These methods involve the synthesis of pyrrolidine rings via cyc1ization of 
bis-homoallylic amines/9 1,3-dipolar cyclization,40 reduction-cyc1ization of y-aza 
ketones,4l and Rh-catalyzed C-H insertion. l The method of choice, however, is 
asymmetric lithiation, which has been intensively investigated and extensively reviewed. 
42 This approach is discussed below. 
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J.3.a. Asymmetric Lithiation-Substitution Alpha to Nitrogen 
Asymmetric lithiation-substitution alpha to nitrogen was not considered to be feasible 
originally because it was thought that the alpha hydrogens were not acidic enough to be 
deprotonated, even with strong bases.43 Yet, it was soon found to be feasible when 
nitrogen was activated with an electron withdrawing group, which simultaneously 
increased the acidity of the alpha protons while providing a place for the lithium base to 
coordinate to during lithiation (Scheme 10).43 This finding initiated a new field of study 
with which to prepare chiral pyrrolidines, initially in racemic form, but later as single 
enantiomers.42 
~ N / R _R_L_i,_s_o_l_ve_n_t_.~ 
I 
EWG 
57 58 
EWG = ROCO, RCO, RCNR, ROCNR 
R = alkyl 
• 
E 
AN/R 
I 
EWG 
59 
e: 
Scheme 10. An example of alpha to nitrogen lithiation-substitution 
Thus, deprotonation of the carbon atom adjacent to the nitrogen, followed by 
electrophilic substitution not only provides a way to synthesize a functionalized amine - it 
also became an approach to prepare highly enantiomerically enriched products when 
homochiral diamine additives were employed to mediate the reaction (such as (-)-
sparteine, 58). This approach also allowed for control over regiochemistry. A related 
route involving lithiation of already chiral substrates has also been used. In the latter 
method, the lithiation-substitution process IS diastereoselective rather than 
15 
enantioselective when chiral diamines are used. In general, organolithium compounds are 
important reagents in many synthetic organic transformations, and their applications have 
been extended to numerous asymmetric syntheses.42 
1.3.b. (-)-Sparteine-Mediated Enantioselective Lithiation of Pyrrolidines 
Isolated in large quantities by extraction of papilionaceous plants such as Cytisus 
scoparius, the commercially available (-)-sparteine (58) is a very well-known chiral 
diamine in used asymmetric synthesis.44 This diamine has been explored as a ligand in 
asymmetric catalysis with various metals, such as the palladium-catalyzed Wacker 
cyc1ization to synthesize chiral dihydrobenzofurans, or the copper-mediated oxidative 
dearomatization of alkenyl benzaldehydes.45 
~~~ ~~~ H 
58 
Figure 7. (-)-sparteine 
The first enantio-induction observed in a lithiation alpha to a heteroatom using (-)-
sparteine was reported by Hoppe et al. in 1990, who employed sec-butyllithium (s-BuLi) 
to lithiate and a-oxyalkanides 59, the result being that one of the two hydrogens next to 
the oxygen of the carbamate was preferentially removed. Following treatment with 
various e1ectrophiles, this gave their desired products 60 in 52-86% yield and >95% ee.46 
This promising result inspired Beak et al. to apply the same approach using N-Boc 
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pyrrolidine 61 instead of a-oxyalkanides. This procedure afforded 2-substituted N-Boc 
pyrrolidines 62 in 55-76% yield and in 88-96% ee.47,48 The electrophiles used by Beak et 
al. in this process were TMSCI (trimethylsilyl chloride), benzophenone, methyl iodide 
and tributyltin chloride (n-Bu3SnCI).49 
Q~ HH 1. s-SuLi, (-)-sparteine X~ ~E Et20 , - 78°C, 5 h • 
'---A 0--Y 2. E+, Et20 '---A O-{ 
R1 (52-86%) R1 59 60 
(>95% ee) 
Q 1. s-SuLi, (-)-sparteine Q"'/E • Et20, -78°C, 4-6 h N I I 
Soc 
2. e, Et20 
Soc 
61 62 (55-76%) 
(88-96% ee) 
Scheme 11. The first examples of enantioselective lithiation alpha to heteroatoms using 
(-)-sparteine 
Transmetalation from tin to lithium was used to confirm that' the enanttoselective step 
in this reaction occurred during deprotonation with the diamine/alkyllithium complex. In 
this respect, Beak subjected the enantioenriched stannane (S)-63 (96% ee), to 
transmetalation and subsequently quenched with TMSCI to give (S)-65. The retention of 
stereochemistry after transmetalation clearly indicated that the deprotonation with s-BuLi 
and (-)-sparteine gave products with the same relative stereochemistry and that the 
enantiomer produced in the reaction was not affected by the nature of the electrophile. It 
also implied that carbanion 64 was configurationally stable.49 
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Q"I/Sn(n-BU)a 
s-BuLi 
O"I/L' TMSCI Q'I/TMS .. .. 
-78°C N I I I I 
Boc Boc Boc 
(5)-63,96% ee 64 (5)-65, 93% ee 
Scheme 12. Transmetalation from tin to lithium and subsequent electrophile quench 
The intermediate carbanion generated in these asymmetric deprotonation can also 
undergo transmetalation with retention of chirality, allowing for the installation of a wide 
range of functional groups. In 2001, Dieter developed a method to introduce an allyl 
group next to the nitrogen atom in a series of substrates (including N-Boc pyrrolidine) 
with high enantioselectivities.50, 51 The methods involved the use of copper(I) reagents for 
transmetalation after deprotonation with s-BuLi and before addition of allyl bromide 
(Scheme 13). 
o 1. s-BuLi, (-)-sparteine, .. 
~ Et20, -78 °e, 4 h 
O"I/L' N I 
CuCN·2LiCI, 0 ~Br 0 
.. "'I"CU" .. " I/~ THF, -78°C, N N 
Boc 
61 
Q 
I 
Boc 
61 
I I I 
Boc 1 h Boc Boc 
64 66 r; 67 (78% ee) 
1. s-BuLi, (-)-sparteine, Pd(OAch, 
Et20, -78 °e 0 HBF4'P(t-Bub, 0 
---='---'------.. N "I/ZnCI ----"'------'----------'-"-'-----.. N "liAr 
2, ZnCI2 ArBr, THF 
I I 
Boc Boc 
68 69 
Scheme 13. Allylation of N-Boc pyrrolidine 
Eventually, enantioselective palladium-catalyzed a-arylation of N-Boc-pyrrolidine 
carbanion was also reported to give enantiomerically enriched 2-arylpyrrolidines 69. This 
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reaction proceeds by way of a zinc species, which then undergoes a Negishi cross-
coupling with an aryl bromide, catalyzed by palladium acetate in combination with t-
BU3P·HBF4. This method provided the arylated product in 92% ee and 72-82% yield 
Scheme 13.52 
Other than N-Boc pyrrolidine, Metallinos and coworkers have reported that (-)-
sparteine mediated asymmetric lithiation alpha to nitrogen is also feasible with urea-fused 
piperidines. Following a similar procedure, an octahydrophenanthroline-derived urea 70 
was deprotonated and subsequently reacted with electrophiles to give 71 in low yield and 
moderate enantioselectivities (Scheme 14).53 An in-depth transition state analysis for the 
deprotonation of urea 70 by the i-PrLi·(-)-sparteine complex was carried out at the 
MP2/6-316(d)//B3LYP/6-316(d) level of theory. The result indicated the removal of the 
equatorial pro-S hydrogen is favoured over the axial proton, which follows into the trend 
observed in 61 and N-Boc-piperidine.54, 55 
1.2.2 equiv ~PrLi, (-)-sparteine. c9:J 
Et20, -78°C, 4 h N N . 
2. CH31 . n (I \. 
° (25-30%) 
71 
(84:16 er, 68% ee) 
Scheme 14. Lithiation of piper idyl-fused urea 70 
The transition states (TS) for both pro-R and pro-S hydrogen removal showed that the 
A-ring of (-)-sparteine is directly on top of the site of proton transfer (Figure 8). 
Interactions between a ~-CH2-hydrogen in the A-ring of (-)-sparteine and the axial-
hydrogen of 70 alpha to nitrogen not undergoing deprotonation controlled the 
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stereochemistry of the reaction. 53 As shown in Figure 8, the H···H distance between the 
~-CH2 in the A ring and the axial hydrogen of the a-car,bon in TS2 is 2.18 A. This close 
contact leads to destabilization in TS2. On the other hand, the H"'H distance in TSI is 
2.41 A, which is close to the sum of the van der Waals radii of two hydrogen atoms. The 
!'lM value calculated from quantum chemical transition state study was 1.26 kcallmol, 
implying an enantiomeric ratio (er) 89:11 favoring the pro-S equatorial proton removal, 
which is in agreement with the experimental results. The predicted stereochemistry of the 
reaction was confirmed by crystallographic analysis. This computational analysis also 
provided an explanation for why the A-ring of (-)-sparteine is so important for obtaining 
high levels of enantioinduction.54, 55 
B-CH2 . 
L A-rmg H ",I ~N----"''''-''~ 
2.18 A H : \ 
" I ~ '6!j~n---Li '" ~ .', - N IN. ~ b -H-i' 1))( D-rmg 
Me Me 
. . 
TSI (pro-S) TS2 (pro-R) 
Figure 8. Transition states for pro-S-72 and pro-R-72 lithiation53 
Although (-)-sparteine has generated highly enantioenriched products in asymmetric 
lithiation, there are difficulties in producing opposite enantiomers in these reactions due 
to the lack (+ )-sparteine. Unlike its enantiomer, (+ )-sparteine is only available in small 
quantities from nature or through synthetic preparation. 56 
20 
In 1995, the Beak group published the results of roughly 20 chiralligands 73-85 used 
III asymmetric deprotonation of N-Boc pyrrolidine 6.1 in which all reactions were 
quenched with TMSC1.54 However, none of these chiral ligands produced comparable 
results as that of (-)-sparteine.54 Based on these findings, O'Brien and co-workers 
initiated a research focus on the synthesis of diamines that would behave as (+ )-sparteine 
surrogates. 56 
~~ I 0--0 ~ a NMe2 /N'J) N '/NMe2 
I HO HO I OH 
73 74 75 76 
77 
O%ee 
72% ee 30% ee 18% ee O%ee 
~~ O--Q o--S O--Q N 0;-N k OH 7 HO I He! I MeO I Ph Ph 
78 79 80 81 
5%ee 19%ee 4 %ee 64%ee 
~N::;p ~p CNJ) ~~OH \ H ~MeO / / 
MeO MeO 
82 83 84 85 
16% ee 20%ee 24%ee 28%ee 
Figure 9. Structures of the diamines studied by Beak et a1.57 
From Beak's Chem3D space-filling diagrams (Figure 10) of a hypothetical (-)-
sparteine/Li54 complex, the D ring of (-)-sparteine appeared to be turned away from the 
"business end,,56 of the complex. In their design process, O'Brien and co-workers 
removed the D-ring, and added a methyl group to that nitrogen, giving an "N-methyl (+)-
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sparteine surrogate". It has been shown that the "N-methyl (+)-sparteine surrogate" gives 
similar but opposite enantioselectivities in the kinetically controlled asymmetric 
deprotonation reactions; however, it gives poor selectivity when used in dynamic 
thermodynamic reactions as compared to (-)-sparteine. 
A B 
86 
Figure 10. Chem3D model of (-)-sparteine44 
Alternative (+ )-sparteine surrogates are chiral cyclohexyl diamines (89-92, Scheme 
15) which were first synthesized by Alexakis' group58,59 and were employed in 
asymmetric syntheses by Bailey55,60. These diamines were subsequently tested by both 
Alexakis and O'Brien for their selectivity and reactivity compared to (-)-sparteine in 
various organolithium reactions.61 In a series of 2008 publications, O'Brien explored 
:;; . 
these diamines in an asymmetric deprotonation of N-Boc pyrrolidine. The results 
obtained for silyl adduct 87 were comparable to what would be expected with (+)-
sparteine. These diamines may be produced easily in both enantiomeric forms, thus 
allowing the production of the both enantiomers of87 in high ee.61 ,62,63 
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O 1. s-BuLi, diamine • N -78°C, Et20, 3 h O"fIS'M N I e3 
I I 
Boc 2. Me3SiCI Boc 
87 
d5P '~ CXNM":1 " NMe2 
(-)-sparteine (58) (+)-88 (R,R)-TMCDA,89 
87% yield 84% yield 89% yield (S):(R) = 95:5 (S):(R) = 5:95 (S):(R) = 50:50 
I I I (XN,.p CXN",A-BU (XN~t-BU /- r 
'I /i-Pr " "N~t-Bu "'N~t-Bu 'N 
I I I 
(R,R)-90 (R,R)-91 (R,R)-92 
29% yield 4% yield 72% yield 
(S):(R) = 50:50 (S):(R) = 50:50 (S):(R) = 95:5 
Scheme 15. Screening of chiral diamines in N-Boc pyrrolidine lithiation 
J.3.c. Diastereoselective Lithiation alpha to Nitrogen 
Asymmetric synthesis of primary benzyl amines 95 via oxazoliq,inone derived 
organolithium intermediates was developed by Gawley, giving good yields and excellent 
diastereoselectivities (Scheme 16). The alkylated products (94) were hydrolyzed, 
followed by oxidative cleavage of the amino alcohol to generate chiral primary amines in 
high enantiomeric purity.64 
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Ar~N~ 
'l",.LJO \' 
93 
E 0 
1. n-BuLi, THF, -78 °C ArAN~ 
+ ° • I . 0 
2. E ,-100 C "(''-----1 
94 
Scheme 16. Synthesis of chiral benzylamines from oxazolidones via diastereoselective 
lithiation 
In the case of a bicyclic carbamates or oxozolidones 96, Beak reported that these 
reactions undergo diastereoselective lithiation without the use of chiral diamines owing to 
the presence of a chiral center in the substrate to give products 97 with syn 
stereochemistry.65 It was explained that removal of one of the pro-S protons is favoured 
and the resulting anion is highly configurationally stable. Computational calculations, 
carried out at the PM3 level, showed that the pro-S proton had a much shorter distance to 
the carbonyl oxygen (2.78 A) than the pro-R proton (3.70 A, Figure 11), which 
kinetically favoured lithiation by virtue of proximity of the coordinated alkyllithium to 
the carbonyl oxygen. 
CAi-pr i-Pr Wi-pr i-Pr 1. s-BuLi, TMEDA N 0 • N 0 n Et20, -78°C E n 
o 2.E+ 0 
96 97 
Scheme 17. Diastereoselective lithiation of 96 
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syn-98 anti-98 
Figure 11. Cartoon of syn versus anti-98 carbanions; Calculations were carried out at the 
PM3 level of theory 65 
1.5. Aims and Objectives: 
The lack of convenient access to enantio- or diastereomerically emiched 
pyrroloimidazole derivatives with biological activity, as well as the paucity of annulated 
chiral imidazol(in)ium precatalysts,66 prompted us to explore a viable synthetic routes to 
prepare both of these targets by using asymmetric lithiation of urea 70, using reactions of 
N-Boc pyrrolidine 61 and cyclic carbamate 96 as precedent. Two differept urea starting 
materials, one saturated (chiral) and one unsaturated (achiral), will be prepared to test this 
approach. 
To begin our investigation, unsaturated urea 100 (Scheme 17) will be subjected to 
various conditions, such as different chiral diamines, solvents and alkyllithiums to 
determine the best conditions for enantioselective lithiation. With best conditions 
determined, the scope of the process will be evaluated by using different electrophiles to 
produce variously alpha-substituted products 101. The enantio-emiched 101 will ideally 
undergo dealkylation of the t-butyl group under acidic conditions to give 103, and 
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functional group manipulation (oxalyl chloride or POCh and then reduction) will afford 
the target biologically active compounds 104. Alternatively, direct treatment of 101 with 
POCh will give direct access to chiral annulated imidazolium salts 102, which may serve 
as immediate precursors to NHCs by chlorine-lithium exchange at low temperature. 
~N ~ ~ -~~~ _~~I~~~~,_-n --t-Bu chiral diamine 
o 2. E+ 
100 
+~;~~;c- ~N 
E 
104 
Scheme 18a. Proposed routes to synthetic targets 102 and 104. 
The chiral saturated urea congener 105 will also be synthesized and subjected to 
similar lithiation-substitution to give diastereomerically pure products 106, which may be 
. 6 
converted to as imidazolinium precatalysts 107 or trapped with primary amines in situ to 
give guanidine catalysts 108. 
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~N.... ~~~~i~!~~~~_ ;::eN .... n t-Bu solvent E n t-Bu 
o 2. E+ 0 
105 106 
---------- ..... EQy~t-Bu 
CI fJ 107 
Scheme 18b. Proposed route to chiral annulated imidazolinium salts 107 and guanidines 
108 
2. Results and Discussion: 
2.1. Preparation of 2-tert-Butyl-hexahydropyrrolo[1,2-c]imidazol-3-one (105) and 2-
tert-Butyl-2,5,6, 7 -tetrahydropyrrolo [1,2-c ]imidazol-3-one (100) 
To begin our investigations, both ureas 100 and 105 needed to be readily prepared, 
ideally from a common starting material (Scheme 19).36 Compound 110 6~ 'Yas identified 
as a common precursor to both ureas. Following reported procedures, L-proline 1 was 
protected with CbzCI (benzyl chloroformate) to give carboxylic acid 109, which was 
converted to the t-Bu amide 110 via activation with ethyl chloroformate and addition of t-
butylamine. The overall yield for this process was 81 %. 
~OH 
~ 0 
NaOH, CbzCI ~ ~ ,,~/](OH 
(90%) Cbz 0 
t-BuNH2 ~~'t-BU 
Cbz 0 
1 109 110 
Scheme 19. Preparation of 110 
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Amide 110 was deprotected under standard conditions using cyclohexene and 
palladium on carbon (PdlC) in ethanol to give amine 111 (Scheme 20). Attempts to 
reduce the tert-butyl amide in 111 with lithium aluminum hydride (LiAIH4)1l in refluxing 
tetrahydrofuran (THF) were unsuccessful, even after 16 hours. However, changing the 
solvent to 1,2-dimethoxyethane (DME) allowed for full consumption of the starting 
material 111 to give diamine 112. The volatility of diamine 112 made it necessary to 
convert it directly to urea 105 by treatment with triphosgene and triethylamine in 
dichloromethane (CH2Ch) solvent. This procedure afforded urea 105 in 40% overall 
yield as a colorless oil. That urea 105 was still enantiomerically pure after this sequence 
of reactions was confirmed by chiral HPLC analysis where the minor enantiomer was 
completely undetectable. 
5 mol% Pd/C; 
!\ H abs EtOH !\ H 
';crN't-BU -(9-4-%-0)-0-----,--1 ... - "~/8N't-Bu 
110 111 
DME, reflux 
4 equiv LiAIH4 
Et3N, triphosgene, 
.. en NyN--t_Bu 
o 
105, (S)-urea, (40% overall) 
Scheme 20. Synthesis of 105 
' .. ~~'t-Bu 
H 
112 
e. .' 
The synthesis of the unsaturated urea, 2-tert-butyl-2,5,6,7-tetrahydro-pyrrolo[1,2-
c]imidazol-3-one 100 (Scheme 21), followed a similar procedure as for 2-iso-propyl-
2,5,6,7-tetrahydro-pyrrolo[1,2-c]imidazol-3-one 118 reported by Kiyooka68 in 1981 
28 
(Scheme 22). The procedure involved treatment of 45 with LiAIH4 in THF at room 
temperature, this allowed cyclization to form a new ring. Unlike Kiyooka's system, the 
alcohol 113 and 114 were isolable. This mixture of hemiaminals could be treated with 
dilute acid to provide the desired product, 2-tert-butyl-2,5,6,7-tetrahydro-pyrrolo[1,2-
c ]imidazol-3-one 100 in good yield. 
~~-tBU LiAIH4, cn
OH 
N - • NyN_t-Bu + 
I THF, rt 
Cbz 0 0 
111 113 
O.1MHCI ~ 
II L~~~-t_BU (87%) 1\ 
o 
100 
Scheme 21. Preparation of 100 
enPH 
NyN_t_Bu 
0 
114 
Amino alcohol 113 can be isolated as a single diastereomer through crystallization in 
ethyl acetate (EtOAc). To determine the stereochemistry of this compound, nuclear 
Overhauser effect (NOE) difference spectroscopy was performed in acetone-d6• As 
shown in the 1D-NOE spectrum of 113 (Figure 12), irradiating HB (red proton, upside-
down signal at 5.35-5.33 ppm), enhanced the HA signal (blue proton, upright signal at 
3.81 ppm). This result inferred that these two protons were on the same face of the 
molecule, indicating syn stereochemistry. 
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Figure 12. Selective irradiation difference NOE spectrum for 113 
A possible mechanism for the cyc1ization of Cbz-L-proline compound 111 was 
described in Kiyooka's paper.68 In their studies of solvent effect~ in the re~ciion of (S)-N-
isopropyl-N-benzyloxyl carbonyl) prolinamide 115 with LiAIH4, they discovered that 
only THF at room temperature would lead to 116. Using diethyl ether solvent normally 
reduced the Cbz group. It was proposed that the substrate underwent an elimination from 
intermediate 117 to give the unsaturated urea (118, Scheme 22), unlike in 113/114 which 
were isolable. 
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~O 1 HN-< o 0 
~ 
115 V 
rt, 3 h 
--> a;N-( 
o 
118 
116 117 
Scheme 22. Kiyooka proposed mechanism for cyclization to 11868 
Hydrogenation of 100 provided access to the racemic version of 105, which ensured a 
simple way of preparing racemic alpha substituted congeners for eventual enantiomeric 
purity determinations of products by chiral HPLC analysis (vide infra). Thus, subjecting 
100 to Pd/C in ethanol under one atmosphere of hydrogen for 18 hours yielded the rae-
105 in 94% yield.36 
~ H2 ,Pd/C, ~ Lt.N{-l N -=---- Lt.N{ 1 N V ...... t-Bu V ...... t-Bu II MeOH, rt II 
o (94%) 0 
100 rac-105 
Scheme 23. Hydrogenation of100 to rae-lOS 
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2.2. Diastereoselective Lithiation of 2-tert-Butyl-hexahydro-pyrrolo[1,2-c]imidazol-
3-one 105. 
A computational minimization was carried out on 105 [B3LYP/6-31G(d)] to 
detennine the distances between the urea oxygen atom and the pro-S and pro-R alpha 
methylene hydrogens.36 A large difference in distance would indicate preferential 
lithiation of one hydrogen atom over the other because the alkyllithium base would be in 
closer proximity to one hydrogen upon coordination to oxygen. As shown in the Figure 
13 below, the distances between the urea oxygen and the pro-S proton was 2.505 A 
compared to 3.692 A for the pro-R proton, a difference of 1.187 A. Since the difference 
in distance between the carbonyl oxygen and the pro-R and pro-S alpha hydrogens in 
carbamate 96 (Scheme 17) was calculated by Beak to be 0.92 A, this result indicates that 
alpha lithiation of 105 should be at least as diastereoselective as 96.69,36 
105 
Figure 13. Minimized structure of 10570 [B3L YP/6-31 G(d)]; red = oxygen, blue = 
nitrogen, white = hydrogen, grey = carbon. 
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Lithiation of 2-tert-butyl-hexahydro-pyrrolo[1,2-c]imidazol-3-one 105 was carried 
out at -78°C, the same temperature that was used for N-Boc pyrrolidine. Several 
reactions were performed to determine the most suitable solvent and alkyllithium for this 
transformation. 
CD 1. RLi, TMEDA, 
NyN_t_Bu solvent, -78°C 
o 2. E+, warm up to rt 
1\ 
Me2N NMe2 
120 (TMEDA) 
105 
Scheme 24. Diastereoselective lithiation 105 
THF and diethyl ether (Et20) were used as solvents to establish the better medium for 
this particular reaction. The reaction mixture was treated with 
tetramethylethylenediamine (120, TMEDA) and s-BuLi at kept at -78°C for two hours. 
After this time, trimethylsilyl chloride (TMSCI), trimethystannyl chloride (SnMe3CI) or 
deuterated methanol (MeOD) was added and the product yields determined. As seen in 
(: . 
Table 3, significantly better yields were obtained when the reaction was carrried out in 
diethyl ether, and so this solvent was chosen for subsequent experiments. 
Table 3. Lithiation of 105 with s-BuLi/TMEDA in THF or Et20 
E+ E yield (%) in THF yield (%) in Et2O, 
TMSCI TMS 15 63 
SnMe3CI SnMe3 53 55 
MeOD D 17 32 
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The remaining lithiation-substitution reactions were performed in Et20 with TMEDA 
and s-BuLi. The putative alpha carbanion was then trapped with either benzophenone, 
Me2S04, TMSCI, SnMe3CI or CO2 (from dry ice sublimation). Yields from these 
reactions ranged from 55% to 80%. All ofthe preceding products were obtained as single 
diastereomers, as determined by IH and BC NMR analysis. The syn relative 
stereochemistry was determined by NOE spectroscopy (vide infra).36 
~ 1. s-BuLi, TMEDA, s=o 
Lt.N{ ; N Et20, -78°C, 2 h N N V ----t-Bu ------... E V -t-Bu 
~ 2. E+, -78°C to rt ~ 
105 121-126 
Scheme 25. Diastereoselective lithiation-electrophile quench of 105 in Et20 
Table 4. Electrophiles employed in the diastereoselective lithiation of 105 
E Product yield, % r;; .' 
Ph2CO Ph2COH 121 60 
Me2S04 Me 122 55 
allyl bromidea allyl 123 50 
SiMe3CI SiMe3 124 63 
SnMe3CI SnMe3 125 55 
CO2 C02H 126 80 
a via CuCN·2LiCI transmetalation. 
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F or slower reacting electrophiles such as allyl bromide, Dieter has shown that 
transmetalation to the copper speCIes preserves stereochemical integrity of the 
carbanion.5o Thus, transmetalation of the alpha lithio intermediate with CuCN·2LiCI 
before addition of allyl bromide gave 123 in 50% yield, again as a single diastereomer. It 
is worth mentioning that omitting the copper (I) transmetalation step for the electrophile 
benzyl bromide resulted in formation of a diastereomeric mixture of benzylated products 
in low yield (this result was not included in the thesis for lack of complete 
characterization of the products). On a related note, an attempt to perform a Negishi 
coupling to produce arylated product 127 was unsuccessful at room temperature after 
transmetalation with ZnCh. 
1. s-BuLi, TMEDA'o-78 °C AJ 
2. ZnCI2 , 1 h, -78 C 'I /~ NVN ..... t-Bu 3. PhBr, Pd(OAch, Ph II 
(t-BubP·HBF4' rt 127 0 
Scheme 26. Attempted arylation of 105 
To determine the stereochemistry of the preceding products, NOESY or difference 
NOE experiments were carried out. For the benzophenone adduct, a Heteronuclear Single 
Quantum Coherence (HSQC) NMR experiment was carried out to identify the proton-
carbon connectivities. The methine protons of interested were at 4.25 ppm and 3.73 ppm 
(Figure 14). 
35 
u • .. J • ~A L ppm 
, 
- • .~ 
• 
. 0 E- 30 
E- 40 
--------; , 
• • 
E- 50 
----; 
---' ~ 
E- 60 
-
.. 
E- 70 
IJODo 
E- 80 
l- 90 
t- 100 
c- 110 
E- 120 
,..03.' 
E- 130 
E- 140 
~ 
1 'I 1 1 1 
8 7 6 5 4 3 2 ppm 
Figure 14. HSQC spectrum of 121 
In the NOESY spectrum of 121, a correlation cross peak between these same methine 
protons (green and blue) were observed (Figure 15). This result suggested that the two 
protons were on the same side of the molecule, which supported the syn stereochemistry 
of the products. This result coincides with Beak's observation on cyclic carbamate 96. 
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Figure 15. NOESY spectrum of 121 
To confinn the syn stereochemistry of the other products, ID-NOE spectroscopy was 
carried out for 122, 123 and 125. In all three cases, experiments clearly showed that the 
methine protons of interest were on the same face of the molecule, as in 121. For 
example, in the ID-NOE of 122, irradiation of a proton from the pyrrolidine methylene 
groups at 2.1 and 1.9 ppm led to enhancements of the key methine protons at 3.8 and 3.6 
ppm. Similar enhancements were observed in the I-D NOE spectra of 123 and 125. 
37 
~ 1 ---+~ /3.795 /3.776 -3.781 
- j "'-3.753 ~3.768 Col 1 ./3.645 3.750 ~3.634 y= 01 ~ ~3.625 l'I 3.628 , 3.614 01 ~ ~ 3.620 .... ~ 3.543 
3.613 
(JQ Col 
·3.529 = :c. l 3.515 Col 3.603 
"'I 
:c. 
f·127 
tD 
r 3.145 ~ 
2.534 'i" Col /? 3.129 
2.178 
-
t" y 3.115 
Col I 2.119 I 2.105 ill I J 2.106 tJ 2.093 ~ 2.100 Z Col 2.083 . " 2.098 0 2.073 I' \ :- I 0 Col 2.094 trJ 2.056 0 O==<.Z "/I 2.088 til 1.951 2.080 I\) ~ 0, 1.947 2.076 - Z ~ 1.939 I\) 
/ 2.068 
(') 
1.936 0, 
2.055 
..... 
'i'" 
..... 
<: I\) 
"1.929 OJ 1.958 
~ 01 1.927 c: 1.951 
..... 
::t 1.920 f-I 1.945 8. "1.916 01 
1.942 
I\) 
1.909 
-1.938 
..... 
:c. a 
1.905 
1.932 
..... 
"1.669 I\) 
-1.929 
0 
::s 
I\) 1.664 :c. 
1.922 ~ ill 
-1.658 
1.9'18 ~ 1.614 l 1.689 ~ ( 1.576 f-I 1.683 "'I ..... I\) I\) 1.675 S 0 :r1.498 
-1.575 
~ 
V420 a i 1.404 L 1.571 '/f1.398 I\) \ 1.561 til ~ 0 0 .. 1.545 ~ 0, f 362 
-=r [1.533 ~ IC·349 r:: I 1.525 ::l: .. 1.517 I .. 0, ~ GI 't l.312 1.507 N ~1.497 N ~ ~r1.283 1.486 .. r 276 .. 1 -r·448 :c. f l.261 01 ~1.431 " T ~1.252 " y 1.416 /1.223 " " 33 w 
00 
The syn stereochemistry of 125 was further confirmed by transmetalation of tin with 
n-BuLi at low temperature, which after 4.5 h was , treated with Me2S04 to give 
exclusively syn-122. This experiment also showed that the alpha-lithio intermediate is 
configurationally stable for prolonged periods at low temperatures. 
;:CN_t-Bu 
Me3Sn II 
o 
125 
1. n-BuLi, Et20 
-78°C, 4.5 h 
.. ~N_t-BU 
o 
(-)-syn-122 
Scheme 27: Transmetalation of 125 to syn-122 
2.3. Enantioselective Lithiation-Substitution of 2-tert-Butyl-2,5,6,7-tetrahydro-
pyrrolo[I,2-c]imidazol-3-one 100 
Following the example ofphenanthroline-derived urea 70, computational calculations 
of the transition states of lithiation of unsaturated urea 100 with 58·i-PrLi",c.omplex were 
carried out at the MP2/6-316(d)//B3LYP/6-316(d) level. In transition state 1 (TS1, pro-
S), the axial proton of 100 was calculated to be 2.347 A away from the P-CH2 of 58. In 
contrast, TS2 (pro-R lithiation) gave an analogous H···H contact distance of only 2.165 
A, indicating a disfavored and destabilized transition state. Energetically, ~~E for TSI 
and TS2 was found to be 1.68 kcallmol, which corresponds to a predicted enantiomeric 
ratio (er) of94:6 (88% ee) for lithiation of 70 with 58·i-PrLi. 
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TSI: pro-S 
r.; .' 
TS2: pro-R 
Figure 17. TSI and TS2 showing key contact distances between reagent and substrate70 
(red = oxygen, blue = nitrogen, white = hydrogen, grey = carbon; purple = lithium) 
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Unlike the saturated urea 105, unsaturated urea 100 does not contain a chiral center to 
induce stereo selectivity during lithiation reaction. As the model above shows, the use of 
chiral ligands 92 and 128, in addition to 58, may be required to mediate an asymmetric 
lithiation with high selectivity. The intermediate carbanion is expected to be 
configurationally stable until it is trapped with electrophiles. Besides the chiral ligands, 
solvents and alkyllithium size will likely have a significant influence on the reaction 
outcome.36 
1. RLi, 58, 92 or 128, -fY 
solvent, -78°C, 2 h -
----------- N N-- t-Bu 2. Ph2CO, Ph n 
-78 °C ~ rt HO Ph ° 
100 I I 129 
CX\\N~tBU N~tBu 
92 I 
CX\\N~ N~ 
128 I 
Scheme 28: Chiral diamines for the asymmetric lithiation-substitution of 100 
For the sake of enantiomeric purity determination, racemic products were prepared by 
6· 
lithiation of 100 with i-PrLi/TMEDA in Et20 at -78°C before electrophile quench. The 
yields of substituted products obtained in this manner ranged form 60-70%. 
Due to ease of chiral HPLC separation, the benzophenone adduct 129 was selected as 
the product with which to screen the enantioselectivity of the process under conditions 
employing various alkyllithiums, solvents and chiral diamines (Table 5). Diamines 92 
and 128 were prepared following a procedure in Alexakis59• 
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Table 5. Lithiation-substitution optimization for benzophenone adduct 129 
L* RLi solvent yield, % er (% ee), 129 
(-)-sparteine s-BuLi EtzO 73 68.5:31.5 (37) 
(-)-sparteine i-PrLi EtzO 64 82:18 (64) 
(-)-sparteine i-PrLi MTBE 67 90.5:9.5 (81) 
(-)-sparteine i-PrL i PhMe 8 82.5:17.5 (65) 
92 i-PrL i EtzO 60 14.5:85.5 (71) 
92 i-PrL i MTBE 62 15.5: 84.5 (69) 
92 i-PrL i PhMe 44 14.5:85.5 (71) 
128 i-PrL i EtzO 52 27.5:82.5 (45) 
As shown in Table 5, the best result was obtained using the combination of (-)-
sparteine and i-PrLi in methyl tert-butyl ether (MTBE) solvent, which after 
benzophenone quench gave 129 in 67% yield and 81 % ee. Performing the reaction with i-
PrLi and (+ )-sparteine surrogate 92 in Et20 gave the antipode of 129 in 60% yield and 
71 % ee. It is interesting to note the large difference in enantioselectivity observed 
between s-BuLi and i-PrLi in the first two entries of the table (37 versus 64% ee, 
1). . . ' 
respectively). A similar observation was made in the lithiation of urea 70 previously. It is 
unclear why two very similar alkyllithiums would give such different enantioselectivities 
in this reaction. 
Applied to other electrophiles (Scheme 29), the optimum i-PrLi/(-)-sparteine/MTBE 
conditions gave Me, allyl, and stannyl derivatives 130-132 in higher enantiomeric purity 
(94:6 to 99:1 er; 88-98% ee) and yields ranging from 61-76%. Phenylation according to 
the procedure described for N-Boc pyrrolidine afforded 133 in lower yield (30%), but 
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similar enantiomeric purity (93.5:6.5 er; 87% ee). The range of ee's for the products (81-
98% ee) is good agreement with the transition state modeling of this reaction (88% ee). 
1. i-PrLi, (-)-sparteine, 
MTBE, -78°C, 2 h ~ 
---------- E)--NyN_t-Bu 2. E+, -78 °C ~ rt II 
o 
129-133 
E+ E product yield, % er (% ee) 
Ph2CO Ph2COH 129 67 90.5:9.5 (81) 
Me2S04 Me 130 63 97:3 (94) 
allyl bromidea allyl 131 76 94:6 (88) 
SnMe3Cl SnMe3 132 68 99:1 (98)h 
PhBrc Ph 133 30 93.5:6.5 (87) 
a via CuCN·2LiCI transmetalation. 
b after transmetalation (n-BuLi, THF, -J 00 DC, 1 h) and Me2S04 quench. 
c via ZnCJ2 transmetalation and Pd(OAc)2 / HBF4·P(t-Buh coupling. 
Scheme 29. Asymmetric lithiation-electrophile quench of 100 
An attempt to confirm of the absolute stereochemistry of 130 by hydrogenation to 
syn-122 (H2' Pd/C, HC02H1MeOH) was precluded by the formation of the anti-122 
stereoisomer (Scheme 30). The absolute stereochemistry of 130 was instead determined 
by reduction of the enamine (NaBH3CN, MeOH/AcOH, reflux), which gave a mixture of 
anti- and syn-122 (Scheme 31). After careful purification, it was found that syn-122 had 
the same specific rotation ([a]D20 -4) as 122 derived from saturated urea 105 ([a]D20 -
4.4). The relative stereochemistry of anti-122 was verified by I-D NOE experiments 
using the method described previously (Figure 18).36 
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~N_t-BU 
o 
130 
P~~-t-BU 
o 
(+)-anti-122 
Scheme 30. Hydrogenation of 130 
~N_t-BU NaBH3CN, P~~-t-BU + ~N_t-BU .. MeOH/AcOH, 
0 reflux 0 0 
130 (+)-anti-122 (-)-syn-122 
Scheme 31. Reduction of 130 to syn/anti-122 
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The relative stereochemistry of the syn- and anti-122 can also be assigned based on 
the BC-NMR data. It has been reported by Hudlicky and others that methyl groups of 
bicyclic ketones such as 13771,72 show different chemical shifts in l3C NMR depending 
on the relative stereochemistry of the compound. As shown in Figure 19, the methyl 
group of syn-137 is at 16.4 ppm while the methyl group of anti-137 appears further 
downfield at 21.3 ppm. The same trend is observed for syn-122 and anti-122, where the 
signals appear at 18.2 and 22.5 ppm, respectively. These results corroborate the NOE 
stereochemical assignments made previously. 
16.4 ppm H 
~ctJB 
syn-137 
18.2 ppm 
~ H H 0 ~N- --'Z Nt-Bu H3C 
syn-122 
21.3 ppm IH H3C~~-R 
H/~ 
anti-137 22 .5 ppm 
I 
o H CH 3 t-BuN~H 
anti-122 
(shown with correct absolute stereochem istry) e; 
Figure 19. Comparison of the BC NMR methyl shifts in 137 and 122 
In addition, transmetalation of stannane 132 (n-BuLi, THF, -100°C, 1 h) and 
subsequent quench with Me2S04 gave 130 with the same optical rotation as 130 made 
directly from 100. This results shows that the enantioselectivity of the process originates 
from asymmetric deprotonation step with i-PrLi/(-)-sparteine-mediated and allows for 
the assignment ofthe relative stereochemistry for all products 129-133. 
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;=CN~t-BU 
Me3Sn II 
1. n-BuLi, THF ~ 
-100°C, 1 h -
-----~ Ny N--- t_Bu 2. Me2S04 II 
o o 
132 130 
Scheme 32. Transmetalation of 132 to produce 130 
2.4. Manipulation of Substituted and Unsubstituted Ureas by Phosphorus 
Oxychloride Activation 
2.4.a. Conversion to Guanidines 
Following a general procedure by Ishikawa, ll, 13 using oxalyl chloride to convert the 
urea to guanidine 141 was unsuccessful. However, the saturated urea rae-1OS was 
successfully converted to guanidine 141 using 1 equivalent of POCh in refluxing 
toluene.73 In this process, the intermediate 3-chloroimidazolinium salt 140 was not 
isolated but treated with benzyl amine in situ to afford the product, an air-stable yellow 
solid, in 40% overall yield. 
POCI3, PhMe, BnNH2 ~ --~ Lt.N~ ~ N VI ~t-Bu (40%) II reflux 
N'Bn 
rac-105 140 141 
Scheme 33. Synthesis of guanidine 141 from rae-lOS 
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2.4.h. NHCs and Palladium(II) Complexes 
The same approach of POCh activation was used with also used with alpha chiral 
substituted ureas, with minor modifications of the procedure. First, the ureas 122, 100 
and 130 were converted to the chloro-imidazol(in)ium salts 142-144 by heating in neat 
POCh. The intermediate salts were then isolated after anion exchange with sodium 
tetraphenylborate (NaBP14). Compounds 143 and 144 were converted directly to NHCs 
by chlorine-lithium exchange with t-BuLi at low temperature. In principle, this exchange 
procedure should work equally well for 3-chloro-imidazolinium salt 142 according to a 
procedure reported by Hong in 2009.74 
To trap carbenes derived from 143 and 144, an inexpensive Pd dimer 14575 was 
prepared according to a literature procedure. This simple procedure involved mixing 
PdCh with dimethylamine in methanol under argon atmosphere for 4 hours. The 
precipitate was then collected and recrystallized from benzene/hexane.74 Addition of 145 
to either 143 or 144 afforded the new Pd(II) complexes 146 and 147 in 40-58%. Product 
147 was a 10:7 mixture coordination isomers, which were not separable by column 
chromatography. 
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S=CN_t-Bu 
Me II 
o 
122 
EQ;N_t-Bu 
o 
100 (E = H) 
130 (E = Me) 
1.POCI3,110°C ~ 
2. NaBPh4, MeOH" Me}-Nyi -..t-Bu 
(63%) CI 8 BPh4 
142 
.. ES=C~t-BU 2. NaBPh4, MeOH I 
CI8BPh4 
143 (E = H) 
(50-70%) 
144 (E = Me) 
_
___________ EQ:;N_t-BU 1. 2 equiv t-BuLi, THF, -78°C _ I 
2. 0.5 eqUiV8~:CI'PdO M~ICI ~ 'C((J v 
~ ~ 145 Me2 146 (E = H) 
(40-58%) 147 (E = Me) 
Scheme 34. Imidazol(in)ium salts of 142-144 and Pd complexes 146 and 147 
lA.c. Manipulation to Biologically Active Compounds 
As mentioned earlier in the Introduction, chiral pyrroloimidazoles have been reported 
to have inhibitory effects on enzymes such as aldosterone synthase, but they have not 
been prepared in an asymmetric manner. To convert the unsaturated compound 100 to 
this imidazole derivative, the t-butyl group would need to be removed. This was possible 
with the saturated urea 105 by heating trifluoroacetic acid (TFA) to produce hexahydro-
pyrrolo[1,2-c]imidazol-3-one 148. However, this procedure did not provide the desired 
product 149 when 100 was subjected to the same conditions. Shi et al. reported N-
dealkylation of other saturated ureas using mixtures of methanesulfonic acid in refluxing 
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hexane,18 however this again did not produce the desired product. Additives such as 
anisole and thioanisole were utilized in conjunction with TF A, but to no avail. The 
reluctance of 106 dealkylate under acidic conditions may be a consequence of the 
enamine moiety, which probably picks up a proton rendering the t-Bu group unreactive. 
~ TFA, thioanisole ~ L~N{ \ N ----" L~N{ \ NH V --t-Bu V II reflux, 48 h II 
o ~4%) 0 
rac-105 148 
TF A, reflux (with anisole, "/" 
Et3SiH, or thioanisole) /" 
~NH n 
o 
149 
Scheme 35. Acid promoted removal of N-t-Bu group in rae-lOS 
Removal of the t-butyl group was also attempted on imidazolium salt 143. Even in 
this case, only starting material was recovered with no sign of product 150. Only strong 
bases such as KOt-Bu were had any effect on 143. Initially it was thought that a 
substitution of the chloride with N-dealkylation had occurred to give 151. However, 
closer inspection of the data revealed the formation of urea 100, which must have formed 
from attack of adventitious water or hydroxide in the reaction mixture followed by 
equilibration to the carbonyl. In any case, the risk of racemization of alpha aryl products 
such as 133 under strongly basic conditions dissuaded attempts to make pyrroloimidazole 
products with potential biological activity. 
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Ol Ny~--t-BU 
CI -BPh4 
143 
TFA, reflux (with anisole,,,-/ Ol 
Et3SiH, or thioanisole) 7"~ NyN 
150 CI 
10equivKOf-Bu, C~ \ Ol 
t-BuOH • N'l~~N NyN--t_Bu 
Ot u 0 (80%) 
151 100 
Scheme 36. Attempts to remove the t-Bu group in 143 
3. Conclusions and Future Work: 
In summary, the lithiation-substitution of the chiral urea 105 with i-PrLi or s-BuLi 
and TMEDA in EhO was highly diastereoselective. Groups introduced at the 5-position 
included carbon substituents such as (diphenylhydroxy)methyl, methyl, allyl and 
carboxyl. Silyl and stannyl derivatives were made with equal facility. Yields for all 
products ranged from 50-80%. The syn stereochemistry of the products was verified by 2-
D NOESY and 1-D NOE selective irradiation experiments.36 
After screening a number of ligand (chiral diamine )-solvent-alkyllithium for 
unsaturated urea 100, it was found that i-PrLi/(-)-sparteine in MTBE afforded the 
benzophenone adduct in 67% yield and 81 % ee. This set of conditions gave access to Me, 
allyl, stannyl and Ph derivatives in 87-98% ee. The phenyl adduct was formed is lower 
30% yield compared to the remaining derivatives (63-76% yield). The stannyl derivative 
was determined to have the highest enantiomeric purity of the series, even after 
transmetalation with n-BuLi at -100°C and Me2S04 quench. In addition, the absolute 
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stereochemistry of the products was determined by reduction of 130 to syn-122, which 
had the same sign of optical rotation as lOS-derived 122.36 
Transformation of saturated 105 and unsaturated urea 100 products into guanidines or 
N-heterocyclic carbenes was possible by formation of imidazol(in)ium salts using POCh 
as a stoichiometric reagent or as solvent. Unsaturated ureas 100 and 130 served as 
immediate precursors to Pd-complexes 146 and 147 by chlorine-lithium exchange of the 
isolated 3-chloro-imidazolium salts.36 
Although headway was made towards the synthesis of aldosterone synthase 
inhibitors, the unforeseen difficulties involving the removal of the t-Bu group precluded 
formation of the desired products. This problem may be addressed by invoking a latent-
N-silyl protecting group strategy as reported by Hoppe for secondary carbamates, and 
summarized in Scheme 37.76 
TMSOTf, TMEDA,.. R 0 Jl ~ 1. 2.0 equiv s-BuLi, TMED~ 
Et20, DoC to rt ° N -78°C, 1 h I 
153 TMS 2.2.5 equiv e , -78°C, 1 h 
Scheme 37. Hoppe's procedure of in situ N-silylation of carbamates 
Applying the same principle, 147 can be protected in situ to give 156, which may 
undergo asymmetric lithiation-substitution to give secondary urea 157 after treatment 
with dilute acid. Products 157 should be easy to convert to chiral 3-chloro-
52 
pyrroloimidazoles 158 and hence to imidazoles 159 by standard dechlorination 
procedures (H2, Pd/C). Derivatives 159 where E = Ar would be biologically active. 
147 
POCI3 
----------------- .. 
156 
EPyN 
CI 
158 
157 
H2, Pd/C 
--------------~ S=CN 
E 
159 
Scheme 38. Alternative in situ N-silyl protection-deprotection route to pyrroloimidazoles 
Finally, even without the removal of the t-butyl group, this annulated system can also 
be useful in synthesis. Stephan and co-workers have shown that bis-t-Bu NHC 160 forms 
a "Frustrated" Lewis Pair (FLP) with the Lewis acid B(C6FS)3 (161) that is able to 
activate small molecules such as H2 to give imidazolium borohydride 162.77, 78 It is 
conceivable that bulky derivatives of 100, such as ether 163, may also participate in this 
t- . 
chemistry to give salt 164. To the best of our knowledge, this would be the first example 
of an FLP reaction involving a chiral NHC. 
... 
160 
CQN--t-Bu + Ph~_:'~' 
Ph OMe 
163 
161 
8(C6FSh 
161 
/ \ 
t-Bu---Ny~--t-B~ 
H H-B(C6Fsh 
162 
H2,PhMe iYN 
· y --t-8u 
Ph +-
Ph OMe H H-B(C6Fsh 
164 
Scheme 40. NHCs as Lewis bases in FLP activation ofhydrogen77, 78 
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4. Experimental: 
General. All reagents were purchased from Aldrich, Fisher Scientific, Acros or Strem 
and used as received unless otherwise indicated. Tetrahydrofuran (THF) and diethyl ether 
(Et20)was freshly dried and distilled over sodiumlbenzophenone ketyl under an 
atmosphere of nitrogen. MTBE was distilled over LiAIH4 under an argon atmosphere. 
Dimethyl sulfate (Me2S04), TMEDA, bromobenzene and TMSCI were all distilled over 
calcium hydride (CaH2)' Allyl bromide was washed with saturated aqueous sodium 
bicarbonate (NaHC03), water, and dried over magnesium sulfate (MgS04), followed by 
distillation under argon atmosphere. Toluene was distilled over sodium under nitrogen. 
Dichloromethane was distilled over CaH2 under nitrogen. Alkyllithium reagents were 
titrated against N-benzylbenzamide to a blue endpoint.79 All reactions were performed 
under argon in flame- or oven-dried glassware using syringe-septum cap techniques 
unless otherwise indicated. TLC plates were stained with phosphomolybdic acid. Column 
chromatography was performed on silica gel 60 (70-230 mesh). NMR spectra were 
obtained on Bruker A vance 300 or A vance 600 instruments and are referenced to TMS or 
to the residual proton signal of the deuterated solvent for I H spectra, and to the carbon 
multiplet of the deuterated solvent for l3C spectra according to values given in 
Spectrometric Identification of Organic Compounds, Seventh Edition, p. 200 and p. 
240.80 FTIR spectra were recorded on an ATI Mattson Research Series spectrometer. 
Low and high-resolution mass spectral data were obtained on a Kratos Concept 1 S 
Double Focusing spectrometer. Enantiomeric ratios were determined on an Agilent 1100 
HPLC system using Chiralpak AS-H or Chiralcel OD-H columns and were compared 
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against racemic material; compounds were detected at 254 nm unless otherwise indicated. 
Optical rotations were measured on a Rudolph Research Autopol III automatic 
polarimeter. Elemental analyses were performed by Atlantic Microlab, Inc., Norcross, 
GA, USA. Melting points were determined on a Kofler hot-stage apparatus and are 
uncorrected. 
Isopropyllithium81 
Lithium granules (5.73 g, 826 mmol) were weighed into a Petri dish filled with paraffin 
oil, and while covered in the oil, the lithium was flattened carefully with a hammer and 
cut to tiny pieces. After quickly rinsed off the oil with pentane, the lithium was placed in 
a two-necked round bottom flash fitted with a condenser and an additional funnel. The 
whole system was immediately flushed with argon. Pentane (100 mL) was added to the 
flask and the mixture was heated to reflux. A mixture of chloropropane (31.4 mL, 0.344 
mol) and MTBE (0.41 mL, 3.44 mmol) was added dropwise to the lithium/pentane 
mixture over 70 mins with stirring. After the addition was completed, the mixture was 
" allowed to reflux for 20 min and then cooled to rt. At rt, stirring was stopped and the salts 
were allowed to settle over 42 h. The supernatant solution was transferred to a 100 mL 
serum bottle under argon. The residual lithium powder and salts were cooled to 0 °C and 
quenched by slow addition of absolute EtOH (30 mL), 95% EtOH (30 mL) and water (10 
mL). 
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(-)-(S)-Pyrrolidine-l,2-dicarboxylic acid I-benzyl ester (109) 82 
This compound was prepared following a literature procedure. A three-
~OH neck round bottom flask containing a well stirred solution of L-proline 
Cbz 0 
(23.0 g, 0.2 mol) in 2 M NaOH (100 mL) at 0 °C was equipped with two 
additional funnels and a thermometer adapter. To this solution was added dropwise 4 M 
NaOH (70 mL) and CbzCI (36.4 mL, 0.24 mol) simultaneously over one hour. The 
resulting solution was stirred at 0 °C for another hour and then it was washed with Et20 
(2 x 50 mL). The aqueous layer was then acidified to pH 1 using 6 M HCI, and it was 
saturated with Na2S04 prior to extraction with EtOAc (4 x 100 mL). The combined 
organic layer was washed once with brine, dried over Na2S04 and the excess organic 
solvent was removed in vacuo to give 109 as a wax-like colorless and clear product 
(45.85 g, 92%); [a]D20 -40.2 (c 2, abs. EtOH); lit82: [a]D20 -39.9 (c 2, abs. EtOH); IH 
NMR (300 MHz, CDCh): b 12-10 (br, IH), 7.36-7.31 (m, 5H), 5.23-5.13 (m, 2H), 4.34-
4.36 (m, IH), 3.61-3.42 (m, 2H), 2.32-1.92 (m, 2H). 13C NMR (75.5 MHz, CDCh): b 
177.2, 176.4, 155.4, 154.5, 136.3, 136.3, 128.3, 128.3, 127.9, 127.7, 127.5, 67.3, 67.0, 
:> 
59.2, 58.7, 46.8, 46.5, 30.7, 29.5, 24.1, 23.3. (lit83 : 13C NMR (75.5 MHz, CDCh): b 
176.8, 176.3, 155.1, 154.3, 136.0, 128.1, 128.0, 127.6, 127.5, 127.3, 127.2,67.0,66.8, 
58.9, 58.3, 46.6, 46.2, 30.5, 29.4, 23.9, 23.1.) 
(-)-(S)-I-Benzyloxycarbonyl-2-tert-butylaminocarbonylpyrrolidine (110) 67 
This compound was prepared according to literature procedure. To a 
~ ~ ' I-B" stirred solution of 109 (27.1 g, 0.11 mol) and triethylamine (15.3 mL, 
Cbz 0 
0.11 mol) in THF at 0 °C was added ethyl chloroformate (10.5 mL, 
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0.11 mol) dropwise with vigorous stirring. The resulting white slurry was stirred for 
another 30 minutes and treated with freshly distilled t-butylamine (11.7 mL, 0.11 mol) 
over 15 min. After 1 h, the reaction was mixture was filtered and the rinsed thoroughly 
with EtOAc (20 mL). The solvents were removed on a rotary evaporator and the crude 
product was redissolved in ethyl acetate (100 mL) and washed with water (50 mL), 
aqueous sodium bicarbonate solution (50 mL) and brine (50 mL). The excess solvent was 
removed in vacuo to give a colourless solid (30 g, 90%), which was then crystallized over 
EtOAc (20 mL) to give a colourless needles 110 (27 g, 80%). [0.]020 -92.0 (c 1, CHCh); 
lit84: [0.]020 -90.2 (c 1, CHCh); IH NMR (300 MHz, CDCh): rotamers, J 7.61 (b, 5H), 
6.55 (b, 0.5), 5.65 (b, 0.5), 5.26-5.05 (b, 2H), 4.19 (b, 1H), 3.50 (b, 2H), 2.30-2.87 (b, 
2H), 1.29-1.21 (b, lOH); BC NMR (75.5 MHz, CDCh): J 128.4, 128.1,67.2,61.1, 50.9, 
45.7,25.8. 
(-)-(S)-2-tert-butylaminocarbonylpyrrolidine (111) 67 
Prepared according to a literature procedure. A solution:of 110 (5.00 g, 
~~'t-BU 0.016 mol) in freshly distilled cyc10hexene (2.53 mL, 0.025 mol) was 
H 0 
stirred under argon atmosphere. To this solution was added 10% Pd/C (100 mg, 2% 
wt/wt) and the mixture was heated to reflux for 45 minutes or until TLC indicated 
consumption of starting material. The reaction mixture was filtered through a pad of 
Celite and rinsed with abs. EtOH (5 mL). Removal of organic solvents in vacuo provided 
the desired product as a colorless solid (2.60 g, 96%). The crude solid was recrystallized 
from hexane (ca. 10 mL) to give colorless and transparent rods (2.30 g, 85%). [0.]020 _ 
77.0 (c 1.0, abs. EtOH); IH NMR (300 MHz, CDCh): J 7.47 (b, 1H), 3.67-3.62 (m, 1H), 
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3.05-2.97 (m, IH), 2.90-2.85 (m, IH), 2.48 (b, IH), 2.17-2.05 (m, IH), 1.92-1.82 (m, 
2H), 1.77-1.67 (m, 2H), 1.33 (s, 9H). I3C NMR (75.5 MHz, CDCh): b 174.3,61.1,49.9, 
47.1,30.6,28.7,26.1. 
(-)-2-tert-Butyl-7aS-hexahydropyrrolo[1,2-c]imidazol-3-one (105). To a solution of 
the pyrrolidine 111 (1.00 g, 5.88 mmol) in dry DME (20 mL) was added 
LiAIHt (939 mg, 24.5 mmol) in three portions. The resulting mixture 
was heated at reflux for 15 h under argon, cooled to 0 cC, and worked 
up with sat. aq. Na2S04 solution (ca. 20 mL). After warming to room temperature, the 
solids were removed by filtration, rinsing with CH2Ch (10 mL). The separated organic 
layer was washed with brine, dried over anhyd. Na2S04 and filtered into a round 
bottomed flask. This solution of volatile diamine was degassed by bubbling argon 
through it for 15 min, and then transferred by cannula into a flame-dried round-bottomed 
flask under argon. To this solution was added triethylamine (2.46 mL) and a solution of 
triphosgene (1.90 g) in CH2Ch (10 mL). The resulting cloudy mixture was stirred at room 
& 
temperature for 15 h, worked up with water, extracted with CH2Ch, dried over Na2S04, 
filtered and concentrated in vacuo to give a yellowish oil. Column chromatography (7:3 
hexane/EtOAc, silica gel) gave urea 105 as a colorless oil (500 mg, 47% from 111); 
[a.]D20 -81 (c 1.0, CHCh); (A = 205 run, Chiralcel OD-H; eluent: 90:10 hexanesli-PrOH, 
1.0 mLimin) determined >99:1 er [tR(major) = 6.64 min, tR(minor) is undetectable]; IR 
(KBr, neat) Vrl/ax 2969, 2902, 1691, 1481, 1406, 1273, 1256 cm-I; IH NMR (300 MHz, 
CDCh): b 3.67-3.45 (m, 3H), 3.27 (d, IH, J = 7.5 Hz), 2.99-2.91 (m, IH), 1.93-1.82 (m, 
2H), 1.80-1.65 (m, IH), 1.33 (s, 9H), 1.39-1.22 (m, IH); I3C NMR (75.5 MHz, CDCh): b 
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163.7,55.6,52.9,45.9,45.3,30.4,27.7,24.9; ElMS [mlz(%)] 182 (M+, 9), 167 (M+-CH3, 
100),60 (20),57 (47); HRMS (EI) calcd for C9HISN20: 167.1184; found 167.1177. 
(-)-2-tert-Butyl-IR-hydroxy-7aS-hexahydropyrrolo[I,2-c]imidazol-3-one (113). To a 
(h0H 
NyN--- t_Bu 
o 
stirred suspension of LiAIH4 (400 mg, 0.10 mmol) in THF (40 mL) at 
o DC was added, dropwise, a solution of Cbz-prolinamide 111 (3.90 g, 
0.013 mol) in THF (10 mL). The resulting suspension was allowed to 
warm to room temperature and stirred for 30 min. After cooling to 0 DC, the mixture was 
worked-up by dropwise addition of sat. aq. Na2S04 solution (5 mL) and allowed to warm 
to room temperature. The solids were removed by filtration, rinsing with CH2Ch (2 x 5 
mL). The resulting solution was dried over anhyd. Na2S04, filtered again, and 
concentrated in vacuo to give a semi-solid mixture that was Kugelrohr distilled (0.1 
mmHg, 70 DC for 30 min) to remove benzyl alcohol, leaving a colorless solid (2.00 g). 
The hemiaminal (113) was crystallized from EtOAc (20 mL, 891 mg, 72%). mp 196-199 
DC (EtOAc); [a]D20 -0.356 (c 0.5, acetone); IR (KBr) Vmax 3228, 2970, 2945, 2879, 
2802,2735, 1657, 1415, 1124, 1026 em-I; IH NMR (600 MHz, CDCh): 65.30 (dd, 1H, J 
= 8.4, 7.2 Hz), 3.89 (q, 1H, J = 6.6 Hz), 3.56-3.51 (m, 1H), 3.06-3.02 (m; IH), 2.26 (d, 
OH, J = 8.4 Hz), 2.01-1.95 (m, 1H), 1.95-1.90 (m, 2H), 1.84-1.79 (m, 1H); l3C NMR 
(150.9 MHz, CDCh): 6 161.0, 80.8, 60.7, 53.2, 45.5, 28.8, 27.2, 24.7; Anal. calcd for 
ClOHI8N202: C, 60.58, H, 9.15; found C, 60.84, H, 9.35. 
2-tert-Butyl-2,5,6,7-tetrahydropyrrolo [1,2-c] imidazol-3 -one (100). To a stirred 
CA suspension of LiAIH4 (400 mg, 0.10 mmol) in THF (40 mL) at 0 DC was 
NyN--t_Bu added, dropwise, a solution of Cbz-prolinamide 111 (3.90 g, 0.013 mol) 
o 
in THF (10 mL). The resulting suspension was allowed to warm to room temperature and 
stirred for 30 min. After cooling to 0 DC, the mixture was worked-up by dropwise 
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addition of sat. aq. Na2S04 solution (5 mL) and allowed to warm to room temperature. 
The solids were removed by filtration, rinsing with CH2Cb (2 x 5 mL). The resulting 
solution was dried over anhyd. Na2S04, filtered again, and concentrated in vacuo to give 
a semi-solid mixture that was Kugelrohr distilled (0.1 mmHg, 70°C for 30 min) to 
remove benzyl alcohol, leaving a colorless solid. To this solid was added 0.1 M aq. HCI 
(130 mL), and the suspension was allowed to stir for 1 h at rt or until all the solid had 
dissolved. The acidic solution was extracted with CH2Cb (1 x 200 mL, 2 x 100 mL) and 
the combined organic phase was dried over anhyd. Na2S04, filtered, concentrated and 
dried under high vacuum to give 100 as a colorless solid (2.05 g, 87%). Recrystallization 
from hexane (60 mL) gave analytically pure material as needle-shaped crystals (two 
crystallizations: 1.80 g, 76%); mp 133-136 °C (hexane); UV (i-PrOH) Amax 218 nm, e = 
2401 Llmol/cm; IR (KBr) Vmax 3126,2977,2964, 1666, 1631, 1421, 1355, 1229 cm-I; IH 
NMR (300 MHz, CDCh): 0 5.97 (s, 1H), 3.65 (t, 2H, J = 6.9 Hz), 2.66 (t, 2H, J = 6.9 
Hz), 2.35 (t, 2H, J= 7.2 Hz), 1.51 (s, 9H); l3C NMR (75.5 MHz, CDCh): 0150.0, 124.7, 
99.0,54.6,41.9,28.3,27.9,22.8; ElMS [mlz(%)] 180 (M+, 17), 124 (100),69 (15); Anal. 
calcd for CIOH16N20: C, 66.63, H, 8.95; found C, 66.83, H, 9.11. 
General Procedure A (lithiation-substitution of (105). A solution of urea 105 (1 
equiv.) and TMEDA (1.2 equiv) in Et20 (0.10 M) was cooled to -78°C. After 15 min, 
this pre-cooled solution was treated dropwise with s-BuLi (1.2 equiv., solution in 
cyclohexane) and the resulting pale yellow transparent solution stirred at -78°C for 2 h 
before dropwise addition of the desired electrophile (1.5 equiv.). The reaction was 
allowed to warm up to room temperature over 16 h. Standard Workup: The reaction 
60 
mixture was worked up by cooling in an ice bath, followed by addition of water (5 mL). 
After separation of the layers, the aqueous phase was extracted with Et20 (3 x 10 mL), 
and the combined organic phase was dried over anhydrous Na2S04, filtered and 
concentrated in vacuo. The crude product was purified by flash column chromatography. 
(+)-2-tert-Butyl-5R-(diphenylhydroxy)methyl-7aS-hexahydropyrrolo[I,2-c]imidazol-
\.h 3-one (121). According to General Procedure A, a solution of 105 
Ph£NyN--- t-su (89 mg, 0.49 mmol) and TMEDA (0.09 mL, 0.59 mmol) in EtzO 
HO Ph 0 
(5 mL) was sequentially treated with s-BuLi (0.51 mL, 0.59 mmol) 
and a solution of benzophenone (135 mg, 0.74 mmol) in THF (2 mL). Standard workup 
followed by column chromatography (silica gel, 8:2 hexane-Et20, Rf= 0.11) gave 121 as 
a colorless solid (103 mg, 60%); mp 177-179 °C (EtOH); [a]D20 +208 (c 1.0, CHCh); IR 
(KBr) Vmax 3187,2985,2956,2924,2872,1660,1417,1278,1156 em-I; IH NMR (600 
MHz, CDCh): b 7.62 (d, 2H, J = 7.8 Hz), 7.42 (d, 2H, J = 7.8 Hz), 7.29 (t, 2H, J = 7.8 
Hz), 7.23 (t, 2H, J= 7.8 Hz), 7.19 (t, IH, J= 7.8 Hz), 7.15 (t, IH, J= 7.8 Hz), 7.13 (s, 
ti-
IH), 4.25 (dd, IH, J = 9.6, 6.6 Hz), 3.73-3.69 (m, IH), 3.54 (t, IH, J = 8.4 Hz), 3.17 (dd, 
IH, J= 9.0,3.0 Hz), 2.10-2.03 (m, IH), 1.88-1.82 (m, IH), 1.48-1.42 (m, IH), 1.40-1.33 
(m, IH), 1.28 (s, 9H); BC NMR (150.9 MHz, CDCh): b 162.0, 147.7, 146.2, 127.9, 
127.7, 126.7, 126.5, 126.3, 126.1,67.4,56.7,53.4,46.9,28.8,27.6,26.4; Anal. calcd for 
C23H2SN202: C, 75.79, H, 7.74; found C, 75.74, H, 7.85. 
61 
(-)-2-tert-Butyl-5S-methyl-7aS-hexahydropyrrolo[1,2-cJimidazol-3-one (122). 
N According to General Procedure A, a solution of 105 (134 mg, 0.74 N N--. t-Bu Y mmol) and TMEDA (0.13 mL, 0.89 mmol) in EhO (5 mL) was 
o 
sequentially treated with s-BuLi (1.14 mL, 0.89 mmol) and Me2S04 (0.11 mL, 1.11 
mmol). Standard workup followed by column chromatography (silica gel, 8:2 EtOAc-
hexane, Rf = 0.27) gave 122 as a colorless oil (80 mg, 55%). [a]D20 -4.4 (c 1.0, CHCh); 
IR (KBr) Vmax 2965,2937,2872, 1691, 1401, 1364, 1276, 1241 cm-I; IH NMR (600 MHz, 
CDCb): J 3.68-3.72 (m, 1H), 3.63-3.58 (m, 1H), 3.50 (t, 1H, J= 9.0 Hz), 3.11 (t, 1H, J= 
7.8 Hz), 2.07-2.03 (m, 1H), 1.93-1.88 (m, 1H), 1.66-1.62 (m, IH), 1.55-1.48 (m, 1H), 
1.36 (d, 2H, J = 6.6 Hz), 1.31 (s, 10H); BC NMR (150.9 MHz, CDCb): J 160.6, 56.3, 
53.0,52.9,48.6,35.2,29.7,27.4, 18.2; ElMS [mlz(%)] 196 (M+, 10), 181 (100); HRMS 
(EI) calcd for CllH20N20: 196.1576; found 196.1577. 
(+ )-2-tert-Butyl-5R -allyl-7 as-hexahydropyrrolo [1 ,2-cJ imidazol-3-one (123). 
According to General Procedure A, a solution of urea 100 (87 mg, 
, 
>t 
0.48 mmol) and TMEDA (0.09 mL, 0.58 mmol) in Et20 (5 mL) was 
sequentially treated with s-BuLi (0.37 mL, 0.60 mmol) and a solution 
of CuCN (21 mg, 0.24 mmol) and LiCI (20 mg, 0.48 mmol) in THF (1 mL). After one 
hour at -78°C, allyl bromide (0.06 mL, 0.74 mmol) was added to the mixture. Standard 
workup followed by column chromatography (silica gel, 9: 1 hexane-EtOAc, Rf = 0.11) 
gave 123 as a pale yellow oil; [a]D20 +10.4 (c 0.45, CHCb); IR (KBr, neat) Vmax 2972, 
2930, 2874, 1686, 1406, 1237 cm-I; IH NMR (300 MHz, CDCb): J 5.80-5.65 (m, IH), 
5.08-4.98 (m, 2H), 3.78-3.67 (m, 1H), 3.55-3.45 (m, 1H), 3.48 (t, 1H, J= 8.1 Hz), 3.08 (t, 
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1H, J= 8.1 Hz), 2.92-2.80 (m, 1H), 2.33 (dt, 1H, J= 13.8,7.0 Hz), 2.00-1.66 (m, 3H), 
1.48-1.42 (m, 1H), 1.29 (s, 9H); 13C NMR (75.5 MHz" CDCh): b 160.1, 135.6, 117.1, 
56.6, 56.4, 53.0, 48.6, 35.3, 32.1, 29.6, 27.5; ElMS [mlz(%)] 222 (M+, 6),207 (15), 181 
(53), 125 (100), 57 (24); HRMS (El) calcd for C13H22N20: 222.1732; found 222.1735. 
(-)-2-tert-Butyl-5S-trirnethylsilyl-7aS-hexahydropyrrolo[1,2-c]irnidazol-3-one (124). 
According to General Procedure A, a solution of 105 (69 mg, 0.38 
~N__ mmol) and TMEDA (0.07mL, 0.46 mmol) in Et20 (4 mL) was 
Me3Si)-Nyi t-Bu 
o treated sequentially with s-BuLi (0.34 mL, 0.46 mmol) and 
TMSCI (0.07 mL, 0.58 mmol). Standard workup followed by column chromatography 
(silica gel, 8:2 hexane-Et20, Rf= 0.11) gave 124 as a colorless oil (61 mg, 63%); [a]D20 _ 
52 (c 1.2, CHCh); lR (KBr, neat) Vmax 2960, 1695, 1408, 1245 em-I; IH NMR (600 MHz, 
CDCh): b 3.59-3.52 (m, 2H), 3.20-3.19 (m, 1H), 2.41 (dd, IH, J= 10.2, 8.4 Hz), 1.99-
1.94 (m, 1H), 1.88-1.83 (m, 1H), 1.65-1.59 (m, 1H), 1.50-1.43 (m, 1H), 1.32 (s, 9H), 0.16 
(s, 9H); 13C NMR (150.9 MHz, CDCh): b 162.3, 56.6, 52.7, 50.3,46.8, 31.3,27.7,27.6, 
:; 
-0.85; ElMS [mlz(%)] 254 (M+, 22), 239 (57), 207 (45), 197 (79), 183 (85), 125 (91), 57 
(100); HRMS (El) calcd for C13H26N20Si: 254.1814; found 254.1803. 
(-)-2-tert-Butyl-5S-trirnethylstannyl-7aS-hexahydropyrrolo [1,2-c]irnidazol-3-one 
~ (125). According to General Procedure A, a solution of 105 (90 
)-Nv N-- t Bu Me3Sn I( - mg, 0.49 mmol) and TMEDA (0.09 mL, 0.59 mmol) in Et20 (5 
o 
mL) was sequentially treated with s-BuLi (0.43 mL, 0.59 mmol) and SnMe3CI (0.74 mL, 
0.74 mmol, solution in hexane). Standard workup followed by column chromatography 
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(silica gel, 9: 1 hexane-EhO, Rf = 0.11) gave 125 as a colorless oil (103 mg, 60%); [a]D 20 
-13 (c 1.0, CHCb); IR (KBr, neat) Vmax 2962,2939,2908,2870, 1680, 1412, 1273, 1257 
em-I; IH NMR (600 MHz, CDCb): lJ 3.61-3.55 (m, 2H), 3.25-3.24 (m, IH), 2.70 (t, IH, J 
= 8.1 Hz), 2.04-1.96 (m, 2H), 1.74-1.71 (m, IH), 1.40-1.38 (m, IH), 1.34 (s, 9H), 0.12 (s, 
9H); l3C NMR (75.5 MHz, CDCb): lJ 163.7,56.2, 52.7,46.02,45.99,31.5,29.4,27.6,-
7.7; ElMS [mlz(%)] 331 (M+-CH3, 30),181 (17), 125 (100), 57 (25); HRMS (EI) calcd 
(-)-2-tert-Butyl-3-oxo-7 as-hexabydropyrrolo[I,2-c ]imidazole-5R -carboxylic acid 
~ (126). According to General Procedure A, a solution of 105 (69 )-NyN--- t_su H02C II mg, 0.38 mmol) and TMEDA (0.07,0.46 mmol) in Et20 (4 mL) 
o 
was treated sequentially with s-BuLi (0.34 mL, 0.46 mmol) and 
dry ice (bubbled into the reaction after passing through an anhydrous calcium chloride 
tube). Following standard work-up, a colorless solid 126 was obtained; mp 208-210 DC; 
[a]D20 -59 (c 1.35 , CHCb); IR (KBr) Vmax 2981, 2933, 2884, 2784, 2702, 2567, 2499, 
1746, 1633, 1433, 1294 em-I; IH NMR (300 MHz, CDCb): lJ 9.15 (b, IH)s 4.17-4.13 (m, 
IH), 3.95-3.86 (m, IH), 3.63 (t, IH, J = 8.4 Hz), 3.38 (t, IH, J = 8.7 Hz), 2.32-2.24 (m, 
2H), 2.05-1.96 (m, IH), 1.85-1.74 (m, IH), 1.30 (s, 9H); l3C NMR (75.5 MHz, CDCh): lJ 
174.6, 162.0,58.6,55.7,53.5,50.3,33.3,29.7,27.5. 
Transmetalation of stannane 125 to 122. 
;=eN-I-BU 
Me3Sn II 
o 
125 
1. n-SuLi, Et20 
-78°C, 4.5 h ~N-I-BU 
o 
(-)-syn-122 
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A solution of 125 (96 mg, 0.28 mol) in diethyl ether (6 mL) under argon was cooled to-
78°C, treated with n-BuLi (0.15 mL, 2.07 M, 0.31 mmol) and stirred for 4.5 h. The 
reaction mixture was treated with Me2S04 (0.04 mL, 0.42 mol) and allowed to warm to 
room temperature over 12 h. Water was added (5 mL) and organic solvents were 
removed in vacuo. The aqueous phase was extracted with Et20 (3 x 10 mL) and the 
combined layer was washed with brine, dried over anhyd. Na2S04, filtered and 
concentrated in vacuo. The crude product was purified by column chromatography (silica 
gel, 8:2 EtOAc-hexane, Rf = 0.27) to give syn-122 (12 mg, 22%) as a colorless oil. 
Physical and spectroscopic data matched that reported for 122 above. 
General Procedure B (lithiation-substitution of 100). A solution of (-)-sparteine (1.2 
equiv) in MTBE (0.23 M) at -78°C was treated with i-PrLi (1.2 equiv, solution in 
pentane) and the mixture was stirred for 30 min. A solution of 100 (1 equiv) in MTBE 
(0.06 M) was then added over 30 min, and the mixture was maintained at -78°C for 2 h. 
After addition of the desired electrophile (1.5 equiv) the reaction mixture was allowed to 
::; 
warm slowly to room temperature (about 16 h). Standard Workup: The reaction mixture 
was cooled to 0 °C and treated with distilled water (5 mL), and organic solvents were 
removed in vacuo. The aqueous phase was extracted with CH2Ch (3 x 5 mL), dried over 
Na2S04, filtered and concentrated in vacuo. The crude product was purified by column 
chromatography. 
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(+ )-2-tert-Butyl-5R -( diphenylhydroxy )methyl-2,5,6, 7 -tetrahydropyrrolo [1,2-
0.=\ c]imidazol-3-one (129). According to General Procedure B, a 
PhfNyN--t-Bu mixture of (-)-sparteine (0.08 mL, 0.34 mmol) in MTBE (1.5 mL) 
HO Ph 0 
was sequentially treated with i-PrLi (0.25 mL, 0.34 mmol), 100 
(50 mg, 0.28 mmol) in MTBE (5 mL) and a solution of benzophenone (78 mg, 0.42 
mmol) in MTBE (1 mL). Standard workup followed by column chromatography (silica 
gel, 8:2 hexanes-EtOAc, Rf = 0.13) gave 129 (68 mg, 67%) as a colorless oil; [a]D20 +91 
(c 1.5, CHCh); Chiral HPLC analysis (Chiralcel OD-H; eluent: 90:10 hexanesli-PrOH, 
1.0 mLimin) determined 90.5:9.5 er, 81% ee [tR(major) = 13.35 min, tR(minor) = 23.70 
min]; lR (KBr, neat) Vmax 3187,2985,2956,2924,2872, 1660, 1417, 1278, 1156 cm-I; IH 
NMR (600 MHz, CDCh): 07.82 (s, 1H), 7.39 (d, 2H, J = 7.2 Hz), 7.34 (t, 2H, J = 7.2 
Hz), 7.31-7.24 (m, 3H), 7.24-7.23 (m, 3H), 5.84 (s, 1H), 5.04 (t, 1H, J= 7.2 Hz), 2.52-
2.48 (m, 2H), 2.46-2.41 (m, 1H), 2.13-2.08 (m, 1H), 1.49 (s, 9H); BC NMR (150.9 MHz, 
CDCh): 0 151.2, 144.8, 143.1, 128.1, 127.9, 127.8, 127.5, 127.4, 127.0, 125.8,99.4,81.3, 
66.2, 55.2, 32.0, 28.2, 21.2; ElMS [mlz(%)] 362 (M+, 6), 180 (100), 124 (69), 105 (24), 
.,i' • 
77(16),57 (12). Anal. calcd for C23H26N202: C, 76.21, H, 7.23; found C, 75.95, H, 7.09. 
(+ )-2-tert-Butyl-5S-methyl-2,5,6, 7 -tetrahydropyrrolo [1 ,2-c] imidazol-3-one (130). 
According to General Procedure B, a mixture of (-)-sparteine (0.14 
mL, 0.34 mmol) in MTBE (5 mL) was sequentially treated with i-PrLi 
(0.39 mL, 0.60 mmol), 100 (90 mg, 0.50 mmo1) in MTBE (5 mL) and 
Me2S04 (0.07 mL, 0.75 mmol). Standard workup followed by column chromatography 
(silica gel, 8:2 EtOAc-hexanes, Rf= 0.26) gave 130 as an amorphous glass (61 mg, 63%); 
66 
[a]D20 +72 (c 1.05, CHCh); Chiral HPLC analysis (Je = 218 run, Chiralcel OD-H; eluent: 
99:1 hexanes/i-PrOH, 0.5 mLimin) determined 97:3 er, .94% ee [tR(major) = 34.74 min, 
tR(minor) = 41.23 min]; IR (KBr, neat) Vmax 3044,2978, 1660, 1631, 1229 cm-I; IH NMR 
(300 MHz, CDCh): fJ 5.90 (s, 1H), 4.10 (sextet, 1H, J= 5.7 Hz), 2.71-2.41 (m, 3H), 1.97-
1.86 (m, 1H), 1.47 (s, 9H), 1.40 (d, 3H, J = 6.3 Hz); BC NMR (150.9 MHz, CDCh): fJ 
150.0, 124.5, 98.6, 54.5, 51.4, 36.2, 28.3, 21.4, 19.2; ElMS [mlz(%)] 194 (M+, 20), 138 
(100),123 (19); HRMS (EI) calcd for CllHIsN20: 194.1419; found: 194.1417. 
(+ )-5R -Allyl-2-tert-butyl-2,5,6, 7 -tetrahydropyrrolo [1,2-c] imidazol-3-one (131). 
According to General Procedure B a mixture of (-)-sparteine (0.14 ~N_t-BU mL, 0.6 mmol) in MillE (5 mL) was sequentially treated willi i-PrLi j g (0.39 mL, 0.6 mmol) and 100 (90 mg, 0.5 mmol) in MTBE (5 mL). 
After 2 h, a solution of CuCN (22 mg, 0.25 mmol) and LiCI (21 mg, 0.5 mmol) in THF 
(1.5 mL) was added, and after stirring for 1 hat -78°C, allyl bromide (0.065 mL, 0.75 
mmol) was added. Standard workup followed by column chromatography (silica gel, 1: 1 
& . 
EtOAc-hexane, Rf = 0.47) gave 131 as a pale yellow oil (84 mg, 76%) as a colorless oil; 
[a]D20 + 108 (c 1.0, CHCh); Chiral HPLC analysis (Je = 218 run, Chiralcel OD-H; eluent: 
99:1 hexanes/i-PrOH, 1.0 mLimin) determined 94:6 er, 88% ee [tR(major) = 10.77 min, 
tR(minor) = 12.60 min]; IR (KBr, neat) Vmax 3136, 3076,2973,2933,2872, 1674, 1633, 
1412, 1365, 1223 em-I; IH NMR (300 MHz, CDCh): fJ 5.89 (s, 1H), 5.77-5.63 (m, 1H), 
5.10-5.00 (m, 2H), 4.11-4.04 (m, IH), 2.70-2.70 (m, 1H), 2.64-2.50 (m, 1H), 2.49- 2.31 
(m, 2H), 2.11-2.01 (m, 1H), 1.46 (s, 9H); BC NMR (75.5 MHz, CDCh): fJ 149.9, 133.6, 
124.8, 117.9, 98.7, 54.8, 54.5, 37.2, 32.8,28.2, 21.4; ElMS [mlz(%)] 220 (M+, 30), 164 
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(56), 123 (100), 97 (17), 57 (10); HRMS (El) calcd for CJ3H20N20: 220.1576; found 
220.1572. 
(+ )-2-tert-Butyl-5S-trimethylstannyl-2,5,6, 7 -tetrahydropyrrolo [1 ,2-c] imidazol-3-one 
(132). According to General Procedure B, a mixture of (-)-
sparteine (0.08 mL, 0.34 mmol) in MTBE (1.5 mL) was 
sequentially treated with i-PrLi (0.25 mL, 0.34 mmol) , 100 (50 
mg, 0.28 mmol) in MTBE (5 mL) and Me3SnCI (0.42 mL, 1.0 M solution in hexane, 0.42 
mmol). Standard workup followed by column chromatography (silica gel, 8:2 hexane-
EtOAc) gave 132 as a colorless oil (65 mg, 68%); [a]D20 +220 (c 0.5, CHCh); IR (KBr, 
neat) Vmax 2973, 2920, 2866, 1668, 1632, 1409, 1365, 1219, 755; IH NMR (300 MHz, 
CDCh): 1J 5.96 (s, 1H), 3.46 (dd, 1H, J = 9.6, 6.9 Hz), 2.66-2.48 (m, 3H), 2.32-2.19 (m, 
1H), 1.48 (s, 9H), 0.15 (s, 9H); l3C NMR (75.5 MHz, CDCh) 1J 150.1, 125.1,98.6,54.4, 
41.4, 33.6,28.3,24.6, -9.8; ElMS [mlz(%)] 344 (M+, 13), 329 (26), 273 (19), 165 (18), 
123 (100); HRMS (El) calcd for CJ3H24N20120Sn: 344.0911; found: 344.0907. 
(+)-2-tert-Butyl-5R-phenyl-2,5,6,7-tetrahydropyrrolo[l,2-c]imidazol-3-one (133). 
~N_t-BU 
Pli II 
According to General Procedure B a mixture of (-)-sparteine (0.11 
mL, 0.48 mmol) in MTBE (2 mL) was sequentially treated with i-
o PrLi (0.32 mL, 0.48 mmol), 100 (87 mg, 0.48 mmol) in MTBE (5 
mL) and 1M ZnCh (0.28 mL, 0.28 mmol, solution in THF). After 30 min at -78°C, the 
reaction mixture was aged at room temperature for 30 min and then treated with 
Pd(OAch (5 mg, 5 mol %), t-BU3P'HBF4 (7 mg, 6 mol %) and PhBr (0.042 mL, 0.4 
68 
mmol). The mixture was allowed to stir for 16 h at room temperature. Concentrated 
aqueous NH3 solution (4 drops) was added and the mixture was stirred for 1 h before 
filtration through Celite and rinsing with MTBE (2 x 5 mL). The solvents were removed 
in vacuo and the residue was re-dissolved CH2Ch. The organic layer was washed with 
0.5 M aq. HCI (2 x 5 mL) and water (5 mL), dried over Na2S04, filtered and concentrated 
in vacuo. Column chromatography (silica gel, 6:4 hexane-EtOAc, Rr = 0.10) gave 133 as 
a viscous oil that solidified upon standing (31 mg, 30%). [a]D20 +112 (c 0.8, CHCh); 
Chiral HPLC analysis (Chiralcel OD-H; eluent: 95:5 hexanesli-PrOH, 1.0 mLlmin) 
determined 93.5:6.5 er, 87% ee [tR(minor) = 10.52 min, tR(major) = 11.56 min]; IR (KBr, 
neat) Vmax 2974,2926, 1666, 1632, 1413, 1365 em-I; IH NMR (300 MHz, CDCh): d 7.34-
7.21 (m, 3H), 7.15-7.12 (m, 2H), 6.07 (s, IH), 5.18-5.14 (m, IH), 2.86-2.65 (m, 3H), 
2.32-2.26 (m, IH), 1.53 (s, 9H); BC NMR (75.5 MHz, CDCh): d 150.0, 140.9, 128.6, 
127.3, 125.6, 125.5,99.2, 58.0, 54.8, 38.1, 28.4, 21.5; EIMS [m/z(%)] 344 (M+, 13),329 
(26),273 (19), 165 (18), 123 (100); HRMS (El) calcd for C16H20N20: 256.1576; found: 
256.1580. 
Reduction of 130 to synlanti-122b. 
~N_t-BU NaBH3CN, P~~-t-BU + ~N_t-BU .. MeOH/AcOH, 
0 reflux 0 0 
130 (+ )-anti-122 (-)-syn-122 
A solution of unsaturated urea 130 (555 mg, 2.86 mmol) in MeOH (14 mL) and acetic 
acid (4 mL) was treated with sodium cyanoborohydride (757 mg, 11.4 mmol) and heated 
at reflux for 3 h. After cooling to room temperature, the reaction mixture was poured into 
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10% aqueous NaOH solution (25 mL). The products were extracted with diethyl ether (5 
x 30 mL) and the combined organic layer was washed with water (50 mL), brine (50 
mL), dried over anhyd MgS04, filtered, and concentrated in vacuo. Careful column 
chromatography (300 mL silica gel on a 3.8 cm diameter column, 95:5 CH2Chlt-BuOMe) 
gave, sequentially, anti-122 (180 mg) as a colorless solid, a mixed fraction of anti-122 
and syn-122 (200 mg), and syn-122 (64 mg). The combined yield of anti-122+syn-122 
was 444 mg (79%). 
(-)-syn-122. colorless oil; [(1]D20 -4 (c 0.1 , CHCh); Spectroscopic data matched (-)-syn-
122 obtained directly from urea 17. 
(+)-anti-122. mp 65-68 °C; [(1]D20 +112.2 (c 0.4, CHCh); lR (KBr) 2968, 2916, 2871, 
1681, 1411, 1278, 1257 cm-I; IH NMR (300 MHz, CDCh): b 3.75 (sextet, 1H, J = 7.2 
Hz), 3.49-3.45 (m, 1H), 3.41 (t, 1H, J= 8.1 Hz), 3.17-3.14 (m, 1H), 2.01-1.95 (m, 1H), 
1.79-1.74 (m, 1H), 1.31-1.20 (m, 2H), 1.22 (s, 9H), 1.05 (d, 3H, J= 6.6 Hz); 13C NMR 
(75.5 MHz, CDCh): b 163.3, 54.4, 53.9, 52.4, 45.1, 33.7, 31.3, 27.4, 22.5; ElMS 
[mlz(%)] 196 (9), 181 (100); HRMS (El) calcd for C11H20N20: 196.1576; found: 
196.1578. 
Transmetalation of stannane 132 to 130. 
P:;N' t-Bu 
Me3Sn II 
1. n-BuLi, THF 
-100°C, 1 h N 
- - ---- Ny N--t_Bu 2. Me2S04 II 
o o 
132 130 
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A solution of (+)-132 (56 mg, 0.16 mmol) in THF (3 mL) at -100°C was treated 
dropwise with n-BuLi (0.11 mL, 0.21 mmol). The resulting mixture was stirred at -100 
°c for 1 h, quenched with Me2S04 (0.023 mL, 0.24 mmol) and allowed to warm to room 
temperature over 16 h. Standard workup followed by column chromatography (silica gel, 
8:2 EtOAc-hexane, Rf = 0.26) gave (+)-130 (22 mg, 69%). [a]020 +72 (c 0.8, CHCh); 
Chiral HPLC analysis (A = 218 nm, Chiralcel OD-H; eluent: 99:1 hexanesli-PrOH, 0.5 
mLimin) determined 99:1 er, 98% ee [tR(major) = 35.17 min, tR(minor) = 42.47 min]. 
(-)-2-tert-Butyl-3-chloro-5S-methyl-tetrahydropyrrolo[1 ,2-c] imidazolinium 
tetraphenylborate (142). ~(±) 
rNyN--t-BU A solution of 122 (19 mg, 0.1 mmol) in POCh (0.09 mL) in a sealed 
Ie 
CI BPh4 tube under Ar was heated to 110°C for 16 h. The resulting mixture 
was cooled to room temperature and the excess POCh was removed in vacuo. The crude 
mixture was dissolved in MeOH (0.3 mL), and a solution ofNaBP~ (55 mg) in MeOH 
(0.3 mL) was added dropwise. The resulting precipitate was filtered, washed with cold 
~ 
MeOH and dried under high vacuum to give 142 as a beige powder (33 mg, 63%); mp 
>230 °C; [a]020-107 (c 0.5, CH2Cb); IR (KBr) Vmax 3159,3124,3053,2985,2876,1944, 
1880,1818,1764,1586,1470, 1427 cm-I ; IH NMR (300 MHz, acetone-d6): 07.37-7.31 
(m, 8H), 6.93 (t, 8H, J= 7.2 Hz), 6.78 (t, 4H, J= 6.9 Hz); 4.49-4.36 (m, 1H), 4.29 (t, IH, 
J = 10.5 Hz), 4.20-4.02 (m, 2H), 2.45-2.32 (m, IH), 2.17-2.10 (m, 1H), 2.03-1.86 (m, 
2H), 1.55 (s, 9H), 1.47 (d, 3H, J= 6.6 Hz); BC NMR (75.5 MHz, acetone-d6): 0 165.3 (q, 
}3 C-llB = 49.8 Hz), 153.1, 137.4, 126.4 (q, }3 C-llB = 3.0 Hz), 122.6, 65.8, 61.7, 56.8, 
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55.4, 37.2, 28.9, 28.8, 19.7. FABMS [m/z(%)] 215 (M -BP14, 100), 159 (33); HRMS 
(FAB) calcd for C12H2oNl5CI: 215.1315; found: 215.1313. 
2-tert-Butyl-3-chloro-6, 7 -dihydro-5H-pyrrolo [1,2-c Jimidazolium tetraphenylborate 
(143). A solution of 100 (50 mg, 0.28 mmol) in POCh (0.26 mL) in a 
sealed tube was heated to 110°C for 16 h. The resulting mixture was 
cooled to room temperature and the excess POCh was removed in 
vacuo. The crude mixture was dissolved in MeOH (0.5 mL), and a solution of NaBP14 
(105 mg) in MeOH (0.4 mL) was added dropwise. The resulting precipitate was filtered, 
washed with cold MeOH and dried under high vacuum to give 143 as a beige powder 
(100 mg, 70%). mp 197-200 °C; IR (KBr) Vmax 3138, 3048, 2984, 1600, 1579, 1509, 
1477, 1422 em-I; IH NMR (300 MHz, acetone-d6): 07.39 (s, 1H), 7.35-7.31 (b, 8H), 6.91 
(t, 8H, J= 7.2 Hz), 6.77 (t, 4H, J= 7.2 Hz), 4.16 (t, 2H, J= 7.5 Hz), 2.96 (t, 2H, J= 7.8 
Hz), 2.55 (quin, 2H, J= 7.5 Hz), 1.75 (s, 9H); I3C NMR (75.5 MHz, acetone-d6): 0 164.9 
(q, JI3 C-Il B = 49.8 Hz), 139.0, 137.0, 126.0, 122.2, 114.7, 64.1, 49.0, 28.9, 27.8, 24.4; 
:> 
FABMS [mlz(%)] 199 (M-BP14, 100), 143 (41); HRMS (FAB) calcd for CIOHll 5cIN2: 
199.1002; found 199.0996. 
(+ )-2-tert-Butyl-3-chloro-5S-methyl-6, 7 -dihydro-5H -pyrrolo [1 ,2-c Jimidazolium 
;:0 tetraphenylborate (144). A solution of 130 (54 mg, 0.28 mmol) in -(±) NyN--t_Bu POCh (0.26 mL) in a sealed tube was heated to 110 °C for 16 h. The 
CI 8 BPh4 
resulting mixture was cooled to room temperature and the excess 
POCh was removed in vacuo. The crude mixture was dissolved in MeOH (0.5 mL), and a 
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solution of NaBP14 (144 mg) in MeOH (0.5 mL) was added dropwise. The resulting 
precipitate was filtered, washed with cold MeOH and dried under high vacuum to give 
144 as a brown solid (72 mg, 50%); mp 197-200 °C (MeOH/CH2Ch); [a]D20 +28 (c 0.25, 
CH2Ch); IH NMR (300 MHz, CD2Ch): ~ 7.38-7.32 (m, 8H), 7.02 (t, 8H, J = 7.2 Hz), 
6.87 (t, 4H, J = 7.2 Hz), 6.48 (s, IH), 4.38-4.35 (m, IH), 2.77-2.66 (m, 2H), 2.60-2.51 
(m, IH), 2.10-2.04 (m, IH), 1.63 (s, 9H), 1.43 (d, 3H, J= 6.6 Hz); l3C NMR (75.5 MHz, 
CDCh): ~ 163.6 (q, }3C_IlB = 49.8 Hz), 137.4, 135.6, 125.2 (q, }3C_llB = 2.3 Hz), 121.4, 
113.4, 113.4,63.6,58.7,34.7,28.3,22.1, 18.5; FABMS [ml z(%)] 215 (M-BP14, 33), 213 
(100), 159 (15), 157 (46); HRMS (FAB) ca1cd for CllHlS35CIN2: 213.1159; found 
213.1153. 
Di-,..-chlorobis [2-[ (dimethylamino )methyl] phenyl-C,N]dipalladium(lI) 75 
N,N-Dimethyl benzyl amine (0.61 mL, 4.0 mmol) in MeOH (20 
mL) was treated with palladium dichloride (355 mg, 2.0 mmol), 
r). 
and the mixture was stirred for 4 h. The brown heterogenous 
mixture turned from green to brown during this period and the 
mixture was filtered. The collected product was recrystallized from benzene/hexane to 
give the dimmer complex as yellow crystals (384mg, 70%). mp 183-186 °C; IH NMR 
(300 MHz, CDCh): ~ 7.21-7.14 (m, 2H), 7.00-6.94 (m, 2H), 6.91-6.85 (m, 2H), 3.93 (s, 
4H), 2.85 (d, J=8.1 Hz, 12H). 
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2-tert-Butyl-6, 7 -dihydro-5H-pyrrolo [1 ,2-c] imidazol-3-ylidene-[2-
[( dimethylamino )methyl]phenyl-C,N]paUadium(II) chloride (148). 
A solution of 143 (103 mg, 0.20 mmol) in THF (10 mL) at -78°C was 
treated with t-BuLi (0.27 mL, 0.40 mmol) and the reaction mixture was 
stirred for 1 h. A solution of [(dimethylamino)methyl]phenyl-
C,N]palladium(II) chloride dimer (53 mg, 0.10 mmol) in THF (3 mL) was added 
dropwise to the solution of carbene, and the mixture was allowed to warm slowly to room 
temperature. The solvent was removed in vacuo and column chromatography (silica gel, 
eluting with ether, then 10% MeOH in CH2Ch) gave 148 (35 mg, 40%) as a light gray 
solid; mp 221-224 DC; IH NMR (300 MHz, CDCh): J 6.98-6.88, (m, 2H) 6.81 (s, 1H), 
6.71 (td, J= 7.5, 1.2 Hz), 5.93 (d, 1H, J= 7.2 Hz), 4.46-4.40 (m, 1H), 4.15-4.08 (m, 1H), 
3.97 (d, 1H, J= 13.8 Hz), 3.76 (d, 1H, J= 13.5 Hz), 2.89 (t, 2H, J= 7.2 Hz), 2.83 (s, 3H). 
2.77 (s, 3H), 2.51-2.42 (m, 2H), 1.84 (s, 9H); l3C NMR (75.5 MHz, CDCh): J 161.8, 
149.7, 148.2, 135.8, 135.7, 125.3, 123.3, 121.9, 110.9, 72.2, 58.0, 50.9,49.8,48.7, 32.0, 
27.0,23.2; FABMS [mlz(%)] 439 (M+, 12),404 (82), 269 (50), 165 (100), 134 (44), 109 
(74); HRMS (FAB) calcd for C19H2SN3106Pd: 404.1315; found 404.1227. 
N.B. Following the same procedure but adding water instead of 
Chffi N0 N--t-Bu palladium complex to trap the carbene afforded the dechlorinated 
8 BPh4 imidazolium salt (2-tert-Butyl-6, 7 -dihydro-5H-pyrrolo[1 ,2-
c ]imidazolium tetraphenylborate) in 50% yield as a colorless solid; 1 H NMR (300 MHz, 
acetone-d6): J 8.97 (s, IH), 7.65 (s, 1H), 7.36-7.31 (m, 8H), 6.92 (t, 8H, J= 7.5 Hz), 6.77 
(t, 4H, J= 7.2 Hz), 4.42 (t, 2H, J= 7.2 Hz), 3.08 (t, 2H, J= 7.8 Hz), 2.72 (quin, 2H, J= 
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7.5 Hz), 1.72 (s, 9H); FABMS [mlz(%)] 165 (M-BP14, 100), 109 (21), 57(21), 57(8); 
HRMS (FAB) calcd for ClOHI7N2: 165.1392; found 165.1389. 
2-tert-Butyl-5S-methyl-6, 7 -dihydro-5H -pyrrolo [1,2-c] imidazol-3-ylidene-[2-
[(dimethylamino)methyl]phenyl-C,N]palladium(II) chloride (147). A solution of 130 
(25 mg, 0.047 mmol) in THF (3 mL) at -78°C was treated with t-BuLi 
(0.07 mL, 0.09 mmol) and the reaction mixture was stirred for 1 h. A 
solution of [( dimethylamino )methyl]phenyl-C,N]palladium(II) chloride 
dimer (13 mg, 0.024 mmol) in THF (1 mL) was added dropwise to the 
solution of carbene, and the mixture was allowed to warm slowly to room temperature. 
The solvent was removed in vacuo and column chromatography (silica gel, 1: 1 
EtOAclhexane) gave 147 (15 mg, 58%), a waxy yellow solid, as a 10:7 mixture of 
coordination isomers. mp 175-182 °C; IH NMR (300 MHz, CDCh, 2 isomers): 66.99-
6.66 (m, 8H), 6.10 (d, IH, J= 7.5 Hz), 5.85 (d, IH, J= 7.2 Hz), 4.88-4.81 (m, IH), 4.43-
r;. 
4.35 (m, IH), 4.07 (d, IH, J= 13.8 Hz), 3.93 (d, IH, J= 13.8 Hz), 3.83 (d, IH, J= 13.8 
Hz), 3.68 (d, IH, J= 13.8 Hz), 2.97-2.52 (m, 6H), 2.85 (s, 3H), 2.83 (s, 3H), 2.81 (s,3H), 
2.76 (s, 3H), 2.17-2.08 (m, 2H), 1.95 (d, 3H, J = 6.6 Hz), 1.88 (s, 9H), 1.81 (s, 9H), 1.69 
(d. 3H, J = 6.6 Hz); BC NMR (75.5 MHz, CDCh, 2 isomers): 6 161.4, 161.2, 150.9, 
149.5, 148.2, 147.7, 137.3, 135.8, 135.7, 135.6, 125.4, 124.9, 123.3, 123.1, 121.9, 121.7, 
110.9, 110.7, 72.3, 58.1, 56.8, 56.2, 51.1, 50.8, 50.3, 49.8, 35.7, 35.4, 32.0 (2C), 21.6, 
21.4,21.1; ElMS [mlz(%)] 455 (M+, 24), 284 (37), 84 (100), 57 (53); HRMS (EI) calcd 
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Benzyl-(2-tert-butyl-hexahydro-pyrrolo [1 ,2-c] imidazol-3-ylidene )-amine (rac-141) 
A solution of racemic urea 105 (67 mg, 0.37 mmol) and POCh (0.04 
mL, 0.41 mmol) in PhMe (1 mL) was heated at 65°C for 20 h, and then 
cooled to rt. CH2Ch (3 mL) was added and the ice-cooled mixture was 
treated dropwise with benzylamine (0.16 mL, 1.48 mmol) resulting in the formation of 
beige precipitates. The reaction mixture was heated at 50°C for 24 h and cooled to rt. A 
solution of 1M NaOH (0.37 mL) was added, the aqueous phase was extracted with 
CH2Ch (2 x 5 mL), and the combined extract was dried over Na2S04 and concentrated in 
vacuo. The crude product was purified by column chromatography, eluting with 80:18:2 
Et20-hexane-EhN to give colorless solid 147 (37 mg, 37%). mp 52-57°C; IH NMR (300 
MHz, CDCh): b 7.43-7.41 (m, 2H), 7.30 (t, 2H, J= 7.5 Hz), 7.17 (t, IH, J= 7.2Hz), 4.56 
(q, 2H, J = 20, J = 16 Hz), 3.65-3.62 (m, IH), 3.44-3.37 (m, 2H), 3.22-3.16 (m, 2H), 
1.95-1.86 (m, 2H), 1.80-1.77 (m, IH), 1.59-1.54 (m, IH), 1.42 (s, 9H); l3C NMR (150.9 
MHz, CDCh): b 159.8, 144.1, 127.8, 127.1, 125.5, 57.2, 53.3, 53.2, 52.3, 47.8, 31.0, 
27.6,27.3,26.3; ElMS [ml z(%)] 271 (M+, 43), 214 (100), 70 (43). 
(-)-Hexahydro-pyrrolo[1,2-c]imidazol-3-one (148) 
O'NH n 
o 
In a screw-cap vial, urea 105 (47 mg, 0.26 mmol) was treated with TFA 
(1.5 mL, 6.5 mmol) and thioanisole (0.03 mL, 0.27 mmol). The resulting 
beige mixture was heated to reflux for 48 h. The reaction was concentrated 
in vacuo, and purified through column chromatography on silica gel eluting with 1: 1 
EtOAc-hexane; 5% MeOH/CH2Ch to give a colorless oil (32 mg, 94%). [a]D20 -70 (c 0.5, 
CHCh) IH NMR (300 MHz, CDCh): b 5.48 (b, IH), 3.77-3.56 (m, IH), 3.65-3.56 (m, 
76 
2H), 3.30-3.26 (m, 1H), 3.07-2.98 (m, 1H), 1.99-1.84 (m, 2H), 1.82-1.77 (m, 1H), 1.46-
1.39 (m, 1H); l3C NMR (150.9 MHz, CDCh): 6 165.8, 59.5,45.1,42.9,30.5,25.2; ElMS 
[mlz(%)] 126 (M+, 91),98 (76), 55 (100). 
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5.5 
I I I 
9.5 9.0 8.5 
5.0 
I 
8.0 
I 
4.5 
I 
7.5 
4 . 0 3.5 
I I I I 
7.0 6.5 60 5.5 
I~I 
L "'===== CHANNEL fl .. __ w ...... truel 1H f1 10.20 USl!C 
fLl 0.00 dB 
fLlii' 31l.14263725 W 
2.5 3.0 2 . 0 1.5 ppm SFOl 300.131853.4 Mti~ 51 16384 
Sf 300 .13U0002 MHz 
IHJ~ EM 
5SB 0 
LE 0.30 Hz 
GB 0 
PC 1. 0(1 
I I I I I lit i 
5.0 '.5 ' .0 3.5 3.0 2.5 2.0 1.5 1.0 ppm 
I ~I r~r~\ r§I~~ I~ll~( (~r~ 
89 
~N_t-BU 
TMS II 
o 
124 
150 MHz, CDCI3 
I 
180 160 140 120 100 
Id proton 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
~V~~\-~':'b~~I\fI{i1;77 
3.5 3.0 2.5 2.0 1.5 
~~( I:!i bl I ::{ blbl\::li 
1.0 
80 60 40 20 ppm 
a~R 
tl1lHE .5T.4-161c01 
EY.PNO 1 
~:~;NO 2~CtiO~ 
'I'iJlle- 14."28 
HISTF.UH Splicl 
PReBHO ~ M !?PoSSO SS-
PULPIi.OG z;:!C 
TO 22766 
SOLVEn'i COC13 
lIS 4 
M 0 
SWH Inn.23i Hz 
FlDRES 0.3,16S3 Hz 
AO 1.3239116 sec: 
RG 35 .9 
OM 4C.<OQ u:ilec 
DE 6.00 us ee 
TE 295.1 K 
01 1.00000000 SI.!'C 
TDO 1 
., .......... = CH"'NII£L rl cs"' ...... ;'u. 
Nuel IH 
i'l 11.00 unc 
1'L1 ..,4. 00 dB 
PLltt 31 . S~lE66E2 If 
51'01 600.;: 0)1065 I'IHl: 
51 32168 
Sf 600 . 2(jO(lOOO MHo: 
WOW EM 
SSB 0 
LB 0 . 30 H: 
~ 0 
PC 1.00 
0.5 ppm 
90 
;:eN_t-au 
Me3Sn II 
o 
125 
75 MHz, CDCI3 
j 
I i 
00 .... 
"'..,'" 
";oi"": 
(')(\/(\/ 
\11 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
ld proton 
4.0 3.5 3.0 
)~( b( 
1.0 0.5 
..... "'II:) "'N \DU") ..... ~,.... 
................... 0 
o~V; -BSR NAME sy..cl - 159col 
EXPNO 1 
PROCNO 1 
Datto 200B060:i 
i;~;;UM 4~~~ 
PROBHO 5 J!:m. PASBO BB-
PtTLPROG zg30 
TO 32168 
SOLVENT CDCl3 
NS 4j 
DS 0 
SWH 12376.237 Hz 
flORES U.3716-93 Hz 
AQ 1.3239176 sec 
RG 40.3 
OW 40 . 400 usee 
DE 6.00 usee 
TE 295 . 1 K 
Dl 1. 00000000 sec 
TDO 1 
..... _ - _ ... CHANt-:EL fl --_ .. 
NUCI 111 
PI 11.00 U$t:!C 
-· --PL1 .. ,-·· -.··_- _·,· ,· __ · ... 4 • .QO··dB _ _ ._ __ .... 
PLIW 31.54766682 w 
SFOl 600.2031065 HHz 
51 32168 
SF 600.2000000 MH:: 
flOW EM 
ssa 0 
L8 0.30 Hz 
GS 0 
PC 1.00 
ppm 
91 
B~R 
NAY.!: JX.4- 1liJ- e 
E~MO .l 
PROC.-o J 
Dat .. _ 2009&608 
rift. 22.1E 
;:CN_t-B" 
H02C II 
I'-S TROM spe-ct 
PRaSaD S t:::I l'M~ ~ 
~~LPRO\i ~~1~& 
SOLVElU coeD 
Nfi Z~6 
DS 0 
SifH 119S!:.6U 8% 
l'IDPLS O. S46en !II. 
o AO (I. 9UGOe" nc R.-G ~2 1H 
DM' 2l.BCCi unc 
126 DE E. OO usee n: 2~Y.2 r:: 
D1 ",OCOOO(lOO n~ 
Dil C. 0300CODO ~ .. c 
TDO 1 
---- CK\.~'tEL fl ----
:m':l 13C 
1',1 U.I)(I us." 
I'Ll -2.0(1 ~ 
PL1W 62.:02826£9 W 
'!Iro) 75.475.2~:O Y.H% 
---- tK\.\'NEL f2 ----
CPDl'RG2 waIn16 
Nu::'2 18 
PCPD2 60.00 usa,C' 
I'Ll 0.00 dZ 
pL12 11.89 ~ 
FLU 11.H Q!. 
pL2W )O . 142€3125 W 
I"L12;c C.4aSSan.2 w 
PLB;c O. S23t1U9'! X' 
sro2 300.13120(;(1 t!H:: 
S! l .oS4 
SF 15 . 4611513 to!H: 
W~ ~ 
~~"~"~~""""""" __ " __ "",,~~~,,,~,,,,~~~,,,,,,~~~,,~ .. 5sa ~ ., to!! .1.00 H. G!I (I 
PC loU 
I I I Iii I iii I i I Iii i , 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 .0 30 20 ppm 
~~. ~~~~~~gm~a3~~~~~~~~~~~~~~~ ~ 
____ Q ~~ ~~ NNQO
~~~~~~MM~M~M~~~N~NNNN~~~~~~~ 
~"'-~~":~.!fIY ~j~~ . K.R 
L.X-J 
N1L..~ n.t- liJr~d<)-h2 
r.-:.P~loj l 
~!~' 2 n090(iC~ 
Ti::. 22..4.9 
nstltIDt lpect 
UGIND S .. iA'EO II!-
J"l1LPR~:O : 030 
ID j2H:8 
!iOL"Etlt CD-:lJ 
H!i 4 
D!i C 
SWN 61 n. 839 Hz 
r~DP.E~ 6. 2.~,~~!;~g :!': 
1\'; :n4 
ox 81. DOC uue 
DI. o. ce uue 
Tt 2.99.0 K 
Dl 1 . ('{}(![o(t(oCC s~c 
TOO 
_ ...... -- CKAK~IU fl -_ .. _-... 
NOel 1M 
PI l (i.20 uue 
rLl O. CO .:Ii: 
PLlA" }('.142.6ji2S K 
!iTO::' :!O(·. 1318534 MHz 
Sl 163134 
!iT : ('('. nOO('€2 ~% 
.". '" 
!iSR C 
Li 0.30 HI 
'" C rc :. CC 
~---
i i i i i i i i i i i i i i i i i i 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm 
I~( 1§1~1 1~1~1 l~(~I~r ~I 
92 
.~R 
'tlAv.f:: SXS-1Hcryatl 
!Xf~O 2 
P~Ct;o 1 
Date-_ 20090123 
tUM l ::?H 
U--::U.UM speet 
PF:O!:HD 5 Cl PDEO l!&-
;gLPRO~ %mi, ~ 
SOLVENT CDC}) 
NS' 2~,' 
Of; 0 
SWH 35971. 223 H!. 
nons 1. (191755 Hz. 
AQ O.4SS!!:39'1 ~e-c 
F.G 20':42.5 
OW n.90 fI U!".e 
DE f.f)(I unc 
It; 295 .5 F-
Dl 2. GCCoOGOOfl 2~C 
Ol l 0.01000000 nC' 
ttlO 1 
.--- C~'U:'L f l ----
1UJ~l U..:: 
Pl .LOO U5K' 
I'Ll -1.CO .ce. 
PLlX 902. nSEOMl w 
trot 1 50.9355021 M9: 
---- CHI\!I.'Nla, f2 ----
CPDPP.:i2 ,,·alt:.H 
~~2 18 
p<=vo2 10. 06 unc 
PL2 -1lI.OO ~ 
PL12 12.01 dB 
PLB 1:.00 d! 
pLZ"", 31. :47M6S2 W 
PL12W 0.779116]3 if 
iLl 3;.: D.397H4.U x 
srol 600.2f124002" r.8:: 
S! ~2US 
SF 150.nouoo Y.H: 
il'DiI' EY.. 
sse (I 
............................................ __ ~ ................ ~ ........ .;:~.: 1.C~ H~ 
I 
180 
I 
160 
I 
140 
I 
120 
I 
100 
I 
BO 
I 
60 
I 
40 
I 
20 ppm 
PC 1 . -4(1 
\><J 
BRUKIER 
L><-J 
~11IY.! SKS-l e:sc:rysc 1 
E~~10 1 
PP::IC'NO 1 
Dau,_ 20:090123 
fir", 1:-.14-
IN=n~;OM spt-et 
PP.Ol!HD 5 c:::l PA&;eo 1:5-
~gLPRO~ 3~~~~ 
SOLVDU CDcl3 
liS " D5 6.. 0 
S'K'H 12~1':.2l'1 H: 
fIDUS 0.377'93 Hz 
AQ 1 . ::: ' 2~9176 He: 
:P.G 1 2E' 
DW 40 . 400 IJ:!-ec:: 
D£ ':.00 USE-e:: 
IE 295.1 K 
Dl 1..0000(1000 e~e' 
TOO 1 
---- CR1I...,,-IEL f 1. ----!Iu:l 1M 
pl _1.00 US&C' 
PLl -~.oo $ 
PLIW 31 . S4 78€·6S2 w 
SFol 6QC'. 2(i:nO€.$ v.Hz 
51 321EB 
SF 6ClO. 2 0001 JJO HH% 
;qOW Ev. 
SSE- 0 
LEI (L:!oO Ht 
GE; 0 
PC 1. 00 
1 . ....... '1' ...... "1'"'" ... 1 ......... 1 ...... "'1 ..... " • • ,' ....... "11I ·"'''j".,'"''I'II'"'1I1 
9 8 7 6 5 4 3 2 1 ppm 
(~I r~II~) !~ ~~(~~~) 
93 
75 MHz, CDCI3 
J 
I I 
.... 
III 
... 
III 
I 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
, 
8.5 
i 
8.0 
i 
7.5 7.0 
i 
6.5 
t i 
5.0 4.5 
I I 
4.0 3.5 
I~~ 
I ii i 
3.0 2.5 2.0 1.5 
!~~ I~I I~~ 
aBSR 
flAM;: .~x5-135c:;y,t1hex-h 
EXr~O 1 
PROCNO 1 
~~~~- ~lfOg:ig 
I NS!RUM !lpec:t 
PROE!HD 5 II\rl fl,BBO BiI· 
PULfROG i!:q30 
'1D J 276S 
SOLVgNT COCl3 
NS • 
OS :I 
SWH 61n . !!39 H:: 
0.1IIe3eo Hz 
"0 2.(;542580 ~ec 
RG 645.1 
ow 61.000 us~c 
DE: 6 .00 Il.'<er; 
TZ 297.1 J{ 
01 l.DODOC/ODC sec 
no 1 
.. -"' .. ~.,.. CPJ\NNE'"", t l .. ~"' .... ~ .. "" 
NJCl 1£ 
PI lO . 2!l l.l~eC' 
Pll U. OO dB 
i'LHi 30.H2(3725)oj 
~F01 30C! .131E534 M;::r. 
S1 16384 
SF 300.130006:< MHr. 
WOW F.H 
SSB 0 
LE 0 .30 H .... 
G' 0 
PC 1.00 
i 
1.0 ppm 
94 
o ..... -.:toU') ..... ooco ..... [IS ~N8~ 3i~ q """:l'-o:qc:.'!~""':~C1CJ!f"': 8 8 ~!!~~~~~~~ .,; "":"":""':a:i <D iii "":cO N 0> co t-- t-- t-- co It) MN 
\ \\ I \\j/ I I I I I 
Ho6N_t-BU 
Ph Ph 0 
129 
150 MHz, CDCI3 
I I 
180 160 140 120 100 80 60 40 20 PPIT 
Ie proton B~R 
L><-J 
NAME SX5 ~ 175B 
EXPI>O 1 
PROCNO 1 
~;:_ 2oci~~~~ 6· 
INSTRl:"M specL 
PROBllD 5 ram PABSO 88-
PULPROG Oi'!g30 
TD 3:.<768 
SOLVENT CDC13 
NS , 
DS 0 
51tH 12316.237 HOi'! 
FIDRES 0.377693 i!:z 
AQ 1 . 3:139176 se.c: 
RG /1 . 8 
OW 40 . 400 usee: 
DI:: 6.00 usee 
TE 294 . 9 K 
D1 1.00000000 sec 
TUO 1 
"''''.,..". ... .,.,.,..". CHl,l'lN£L f I --~-~ 
NOel 1H 
1'1 n .oo usee 
---- -------------------.-----·~ttw--3i·:5478_:~~- ·~B--.--
1 
8.0 7.5 7.0 6.5 
~~(~I~~ 
6.0 5.5 5.0 4.5 
I ~( 1~( 
I 
4.0 3.5 
SFOI 600 . 2037065 HHz 
51 32768 
5F 600 . 2000000 MHz 
Nnw EM 
ssa 0 
LB 0.30 Hz 
GB 0 
PC 1.00 
I 
3.0 2.5 2.0 ppm 
~I~ I~l 
95 
'" 
... 
0 
'" 
"'0 ell It) 0 "'''' .... "'CO ~ ...r CD "' ''' Ul UlM '" "l ... '" ~ cO r--.:(l)u:) .;....:. CD <Xl "":0> 
'" 
............ Ul It) M 
'" 
"' ~ I \V \ I I I \ I 
75 MHz, CDCI3 
1 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
==== .. == CHANNEL f1 "'''''''===== 
tlUCl lR 
PI 10.20 usee 
PLl 0.00 dB 
PLlW 30.14263725 Ii 
SFOl 300 . 13185].1 MHz 
5I 16384 
SF 300.1300062 MHz 
WOW EM 
SSB 0 
LB 0 . 30 Hz 
GB 0 
PC 1.0C 
, , I I I I I I I I I I I I j I , I 
9.S 9.0 B.5 B.O 7.S 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm 
(~1 I~l I~( 1~1 ~1~ 
96 
'" ~ '" 0 ex> "'''' .... "'''' ..."'''' ... '" ": '" en 
'" 
... ~ '" ... "'''' f'.:Ll'! "' .... '" ": :! ::? ~ .; "":cOcO ........ ,...:C\icO 
'" 
............ 
., ., 
"''''''' '" I \V V I I I I 
75 MHz, CDCI3 
I 
i I I 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
m~~~m~N~MMo~~ __ ~~m~_~_~~mN~_~MmN~_m~~~~m~o~_m~.m 
mv_m~mmMomm~~~.~N __ O __ ~ m~~~MN_~_ O~~~W.M mw~mMMN~ ~ 
m~~~~ooooooooo~~~~~~~~~ ~W~~~~~ •• VMMMMMMOOOOOOO. 
~~~~m~~~~~.~~~NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN~ 
'"" """" " ,," ',:,' ' tit'" k tkkbb'"titii~ -"-'BR KER 
i i ' i i 
9.5 9.0 8.5 8,0 7.5 
I I I Iii I 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 
1~1~1 I~I I~l 
I I I I I I 
3.5 3.0 2.5 2.0 1.5 1.0 
(~1~1~ll~1 I!I 
L><-J 
NAME sx6- 137-h 
EXPKO 1 
fROCIiO 1 
Date 20090Ell 
t lme- 11.42 
INSTRUH apect. 
PROSHD 5 ma PA8BO BB-
i~LPROG 6 3~~~~ 
SOLVENT " CDC1) 
.s B 
PS 0 
SliH 6172 . 839 Hz 
FIDP.ES 0. 188380 Hz 
AQ 2.65'125 8 0 sec 
RG 45.3 
Dii' 81.00 0 USee 
DE 6 .00 usee 
TE 299.0 J( 
D1 1. 00000000 sec 
'rDO 1 
............... CHANNEL £1 -----"" 
NUCl 1M 
PI 10.20 usee 
PLl 0.00 dB 
PUw 30.14263725 W 
Srol 300.1318534 MHz 
51 16384 
SF 300.1300062 MHz 
WDW EM 
SSB 0 
LB 0.30 Hz 
G8 0 
PC 1.00 
ppm 
97 
M 
, , 
9.5 9.0 8.5 
5=9N-t-BU 
e3Sn 
0 
132 
75 MHz, CDCI3 
1 
i 
I 
.J 
iii iii i ii iii 
190 180 170 160 150 140 130 120 110 100 90 SO 70 60 50 40 30 20 10 ppm 
, , I I I I I I I I 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 
~ (~ ~~I I~I 
_._ ..... _--_.-
I I I 
2.0 1.5 1.0 
(~ 
~::-
lNSTRUM 
PROB"HO 
PULPROG 
TD 
SOLVENT 
.5 
OS 
S~n 
FlORES 
AO 
RG 
'" OS ,. 
01 
TOO 
speet. 
S mm PABBO BB-
Z930 
... 32768 
.... CQC13 
• o 
6172 .839 Hz 
0.18B380 Hz 
2.6S42!i80 .llil!!C 
.. 
B1.000 u!o(!c 
6.00 ust>C 
296 . 0 I< 
1. 00000000 sec 
1 
......... "'- CHAh"'NEL t1 .. =_ ..... 
NUCl lH 
Pl 10.20 usee 
PLl 0.00 dB 
PLIW 30.14263125 W 
SFOl 300 . 1318534 MHz 
51 lE3e4 
SF 300. 1300062 !-!H z 
WOW EM 
sse 0 
LB 0.30 Hz 
08 0 
PC 1.00 
ppm 
~ 
98 
~ 
I 
P:;N_t-BU 
Ph 
0 
133 
75 MHz, CDCI3 
I ,J I ~ .. 
"f "" 'T' 
I i I I i I 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppn 
1. bicyclic urea, iPrLil (-) -spart. I TBME, -78, 2 h; 2 . ZnC12, -78 to rt , 30 min ; 
3 . Pd(OAcJ2 , tBu3-HBF4, PhSr, rt, 16 h; Fe fr 1 (JZIO-141A) \'x"'"J 
~~~~~~~~~~S~;N8~~~~~~~~~~~~m~~~~~m~~~~~~8~~~gmre~II""1l1!1I ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~NN~~~~~~~~~~ / ~ \ 
, ! ! , L t L L .......... ~I) \..", ..... '_!::::,,~.~'-I....-l_ ! ' > t l LL1....b~I...)..1 J J.J.J t J! t ! I d' NAH£ H 
.,'V' ~ -----..,. • P r EXPNO 1 
PROCHa 1 
Date 200907(11 
JJ time- 22.06 INSTRUM •. spect PROBHO 5 min p~O SS-PULPROG Z"930 TD 32168 SOLVENT CDCl3 NS e OS 0 Slia 6172.839 Hi FIDRES 0.18838 0 H: AO 2. 65(2580 sec 
i 
7.2 
I 
2.8 
I 
7 . 0 6.8 
i 
2.6 
6.6 
I 
2.4 
I 
6.4 
I 
6.2 
2.2 
I 
6.0 
I 
2.0 
I 
5.8 
i 
5.6 
1.8 
I 
5.4 
I 
ppm 
l 
1.6 ppm 
I 
3 
l~( I~l I~I 
ilG 128 
OW 81. 000 usee 
DE 6.00 u#ec 
TE 296 . 7 t; 
PI 1.00000000.see 
TOO 1 
.. ., .. "',..= CHANNEL (1 ........ .. 
NUCl IH 
PI 10.20 us ee 
PLI 0 . 00 dB 
PLIW 3(J . 14263n~ w 
5rol 300.1318534 MHz 
SI 16384 
SF 300.1300062 MHz: 
WI* £Y. 
SSE 0 
LB 0.30 Hz 
OB 0 
PC 1.00 
ppm 
99 
-o o 
:;: 
~ 
'" 
'" 
'" g: 
~ l 
l 
098'- !>- 1 ~'- " lQb-
~:j 
1]j3'- t: 
~ 
I~'" 
t 2.04r '" ~~ ... 
aMIr '" g 
• 
• Q... 
... 
~---
~ 
r 
7.355 
7.350 
7.358 
7.3S1 
7.347 
7.342 
7.339 
7.334 
7.325 
7.321 
7.316 
7.313 
7.306 
,;:6.953 
::;:::6.929 
~6.904 6.806 6.783 6.759 
)
4.324 
4.289 
4.254 
.4 .174 
4.151 
4.103 
4.067 
4.059 
. 4.023 
12.797 2.419 2.397 lHi: 2.137 2.117 ~rr~~ IV- 2.040 2.032 2.025 ~~ ~:~~i 1.952 1.923 1.554 
· 1.479 
1.457 
m~i~~~W~ gs~m';i~gTI~;i'~Ui~~1I 
~ ~ ~ 
.... .. ~o ~:.! ~~ .. ~~ ~ g ~ 
~o~ .~ ~g ~ ~ .~~ ~~f)i~E,._t • 
~~ ?, ,. 
I::l 
o 
~ 
~ 
Cl 
f!l 
;;; 
o 
;:; 
8 
is 
co 
o 
Cl 
~ 
l!l 
.. 
o 
'" o 
~ 
~ 
-..J 
0'1 
s:: 
I 
N 
Q) 
_'0 ~ n-{1 
OJCD ~ 
""0 ... 
::r OJ 
"" c:: 
-206.50 
/, 166.27 
,?- 165.61 
\:--1 64.96 
\" ,64.30 
-153.08 
___ 137.37 
~ '26.44 126.40 126.37 
"\." 126.33 
\" ,22.63 
£ 
6' 
:J 
CD 
6. 
c 
/ 65.48 
~ ~= A;~:~ ~30'97 30.71 30.45 30.20 29.94 29.68 29.43 ~~::~ 
19.71 
fDOII)O> 
"!~~~ 
$18~~ 
"'-,V/ 
75 MHz, acetone-de 
.1~ _____ ~IW ___ . __ I~ __ J _______ J~_J __ ~.J __ ___ 
I i I I I I I I I I I I I [I 
200 190 180 170 180 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
, 
7 
~I~(~I~ 
.~R 
L><-) 
NAME sx6- 093salt - h2 
EXPNO 1 
PROCHO 1 
Dati! 200904 2 7 
Timc- 14 . 28 
~~~~~gM 5 1M! PA~B~P:~: 
PULPROG z.g30 
TO 32168 
SOLVENT Acetone 
NS , 
OS 0 
SWI:! 6112.839 p.~ 
t'IDRES 0.18B380 Hz. 
AQ 2 . 65425130 sec 
~ 161 
OW 81. 000 usee 
DE 6.00 usee 
TE 291.0 K 
D1 1. 00000000 sec 
TOO 1 
====== CHANNEL f J .... "' ''''''--
Nuel I H 
PI 10.20 usee 
PLl 0.00 dB 
PLIW 30 . 14.263725 W 
SFOI 3QD.131853( MHz 
51 16384 
SF 300.1300071 MHz. 
WDW EM 
SSB 0 
LB 0 . 30 Hz 
GB 0 
PC 1.00 
ppm 
101 
...... 
o 
IV 
ji]2 
ZIt:: "'-l -
~~J ...... 
~ 
0.99 
7.377 
7.367 
7.362 
7.359 
7.354 
7.351 
7.341 
7.337 
1'7.329 
~ 7.324 
~r~:~: 6 .993 
\
6.897 
. 6.873 
6.850 
-""""' 6.-476 
A~·~~~ 5.316 14.384 r::i~! r 4.362 4.351 1~·~~ 2.739 2.712 2.891 2.688 2.677 v: ~~~ ~~:~~ ~--~~~j~~ 2,072 
2.058 
2.043 
1.625 
1.437 
1.415 
m~~~~~W~l [ig~~m~~~~~~m~,~n~~~11 
:::~::: ~ b 
. iE~~~;; r. I~~L.~§ ~~ ~i ~I . f 
go =~g:~~g~;;[ -g;,gg~~~ o.~g:~f~~·~·· tJ I 
~ ~ .: ~~ ~ ~,;~~ g~ . 
-:g 
gj 
~ 
2i 
gJ 
-~ 
~ 
-:g 
-<> 
g 
8 
~ 
~ 
g: 
gJ 
... 
o 
~ 
IU 
o 
~ 
...... 
01 
s: 
I 
.!'I 
() 
o 
I\) 
() 
,;::;-
. n-d 
m CD 'f€; 
... ,. 
'"'C i'" 
~ m r:: 
/ '64.69 
.,?- 164.04 
~163.38 
"- ,62.73 
/ ,37.5' 
____ 135.64 
~'25.38 125.35 125.31 
" '-125.28 
'- 121.49 
---- ,,3.5, 
/ 63.71 
Yr~~~:~~ 53.56 
53.20 
52.84 
52.48 
-34.74 
-28.42 
- 22.17 
- 18.63 
..... 
o 
w 
Ht~ 
1mr 
'f'O'O'-01 
~ 
~ 
r 6.984 
6.963 
6.937 
6.933 
6.913 
6.909 
8,888 
6.BIl5 
n~~ 
6.731 
6.712 
6.107 
a.BIl7 
}
5.938 
5.914 
14.459 4.454 4.443 1" 4.421 4.416 ~4.113 4,105 4.086 3.994 {?3.947 
___ 3.792 
............. 3.74 
f2.90 V 2.90 2.89 2,88 2.88 , 2.87 
2.868 
2.858 
2.854 
2 .830 
2.770 
2.499 
2.478 
2,453 
2.431 
2.426 
1.840 
m~~~~~~~'~ gmmi~ gTm~,~~~~ = 
;,;., ill,;, .11;;,; ; .. !l!ij;! .. !~ 
~a:g ~ g~~i 
Q , 
'" o 
~ 
o 
8 
<D 
o 
~ 
..., 
o 
Ol 
<> 
gj 
~ 
Co> 
o 
~ 
t] 
~ 
I t 
'--
~ 
--..j 
()"I 
s:: 
I 
.!'I 
() 
0 () 
cT 
1 
\/ 
;: 0=1-< en _ a. I : 
() / 
- .. 
:1 
c:: 
I:: 
-161 .78 
___ 149.74 
--- 148.18 
< 135,81 135.74 
,./' 125.29 
- 123.29 
"'- 121 .91 
-110.86 
/, 77.42 
L-77.00 
"'- 76.58 
"'- 72.23 
-57.96 
/ 50.89 
---49.83 
""-- 48.70 
-31 .95 
- 26.95 
- 23.18 
75 MHz, CDCI3 
• I " ' '' 1' ''''''1' "I' ,Ii I" 'I'" "I' I " .... 1 ...... · 1· .. "" ·1""· .... 1""" I' ... 1 ..... 11 '1 I .. iii I'" 'I '"1'' '' '''' ' 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
300 MHz, CDCI3 
(1.25:1 mixture of coordination isomers) 
104 
B~R 
NAME 8x7-083A-c 
EXPI>lO 1 
PROCNC 1 
One 20091110 
'fimc- U.55 
It<S'l:fHm ,spect 
i'.RCBHP 5 Il.m PABl!O BB-
i.'llLPll.OG tgpg30 
'10 32768 
SOI,VEIH CDCll 
N5 18 
OS 0 
SliH 1798S.611 H: 
FIDRES n.54IJS77 ~z 
AQ 0.9110004 sec 
RG 9195.2 
mo 27.BOO usee 
DE 6.00 usee 
n: 298.1 1\ 
III 4.00000000 sec 
011 0.03000000 set: 
TOO 1 
anti-122 t>n: ....... = CKP-.l;'NEL !"l ...... _ ....... 
ImCl 13C 
Pl 11.00 usee 
?Ll -2.00 de 
;>L11'1 62.50282669 It 
5FCll -15.4752950 MHz 
................. CAA'Nh"E!. t2 ............... .. 
C?DPRG2 wlIltr:H'i 
Nue2 lil 
pel'll;:! 80.00 usee 
PL2 0 .00 dB 
PL12 17.99 dB 
PLl3 17.60 em 
PL2); 30.14263725 l1 
PL121\" 0.48998332 K 
SF02 JOO.BI200\] }I~"~ 
S1 le36~ 
SF 75.4677644 M.lit 
I(~ EM I 
PLI310 C.52?:BlIl97 K 
1fIII._IIII! .. --__ ... W .. IItfI .... ~ ... _~.~~,.. .. _~ ... _.1I!IIi~5 1.og P.z 
PC 1.40 
f f I ...-.or ............ F ... iii I ii I I j I I i 
190 "180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
i i 
12 11 
, 
10 
°m~o~O~~~ON~~MmN~~~N~~m~~MO~_OOM_ ~f'-:f'-:~~~~~~:J:~~~~~q~~~~~~O!~~~~~~;!;~~~ ~ ~:?::7'?':'bbb~·~~~~~~W:;-i;:;;!!~7 BlRtJKE .. 
, 
3 
(~I~r~ ~I~~r~ 
-1 
L><-.J 
J.U.MF. !lC;·c.e3jt,,-h 
EXPNO 1 
E'ROCNO 1 
Oatil :<:l)91l10 
i'~- 14 . 51 
I tlS'fIWM =>pll:;:l 
PROBED 5 = t'1I1150 BR-
PU!.E'}\OG zg30 
'rD 3216S 
SOLVENT COeD 
NS ~ 
m:; 0 
Elf¥' 6112. e39 Hz 
nOnES O. lBS3 60 liz 
AQ 2.6542560 8"'''' 
EI.G 32 
DK El.ooq. U96C 
~~ 2;1 ~t, ~~:,c 
01 l.OOOOOOQO lec 
TDO 1 
~ __ ft~m CRl\.'IN£L (1"''''''''''''''''''' 
lweI 1M 
Fl 10.20 usee 
P1".l !l .on dB 
?!.1W ]O.ltI263nS If 
SfOl ]i)'J . lllS5H Mil: 
EI 1639, 
H JOO.130:!062 MHt 
loiDii E."I 
ssa 0 
LS 0. 30 Ill': 
GS 0 
PC ].00 
ppm 
105 
NOESY and HSQC for 121 
HO~N_t-BU 
III Ph Ph 0 ~JJ~ ~~ppm 
J! 1 j I 1 I ii ~ ! I I j t---, ----!---+--+--, ,---l-- 1-----lI-----r-t---i-t ;--+-
===:=;;;:: I ! i 'Iii Ii ;. I ' ' : i "" ro' I j ! iI I I . , ! Wi ' "I I 
:-- : --! I -+- t--t--tT1---+-+T-r~-
! ! I I ! I I III I! ilL I }-----t---t-----r---i - -t--T----+-1 -+--+I-+-t- ,---1'-- 3 " iii i I 'I I ' °1 " i If ' i 
I I , 'I" 'I • I • i ' I "I 
I ! I r' I ! I ' i 'I Ii!' i r---:--------.-'- -'-i--+--~T---,---' '.,------.-]=T 4 I ' I" i ! iii I , I' Iii o · 
I I " !; I "I 
, 'I I I j I I Iii ' 'I i J I ! 1 1 Ii! : I ! i 
,1-r- J---'--'!iL - 'l------+--+-1-- ----+-- 5 I I ! I I I I I iii ! ! ! 
i! I I I i I I I i I' ," LI 
! ! tt J 1 i 1 ! i -L i -L 
i r-- --I j j I II I ii----I I T 
I, I I i I, I " I I i ! I I I 
I I I I -t , ! I , i I I I I l i I !! ~ i ~ ! I , 1 ! :~~~§~ 1.-1.-" ,--,' --r--r---r--r---1 I ! ! i , 1, ' I ' , ; , I' '" .. I ! "":" i I i I: 1 ! . I i I ' ! ! I i -..l~J-Lj __ 1--_!--t..:..L 1 _____ i ___ J_L_tJ 
H-H NOESY 
2 
6 
7 
8 
B~R 
NAME SX5-13ll 
txPNO 5 
PROCNO 1 
Dat~ 20090408 
'fi.m&- 18.48 
INSTRUM ~pect 
PROSHO 5 lUll. PABBO BB-
PIiLPROG noesygpph 
TO 2048 
SOLveNT CDCl3 
'NS 16 
OS 16 
SWH 6127.451 H~ 
FIOltES 2.991920 Ht. 
1.0 0.16'2484 sec 
RG 456.1 
ow Bl.IiOD use e 
DE 6.00 user::: 
1'£ 295 .1 K 
DO 0.00006'7~9 sec 
01 2.00000000 see 
0 8 0 .30000001 lIIec 
01(; 0.00020000 see 
INC 0 . 00016320 lIIec 
-.-_.,..'" CHANNEL f1 ... _-
NOCl ill 
PI 11.00 usee 
P2 2 2 .00 usee 
PLI -4.00 dB 
PLlM" 3l.547861i82 l1 
Srol 1i00.2027628 HHt 
__ GRADIENT CHANNEL .. ~ 
GPRAHl SINE .100 
GPWM2 SUrE. '100 
GPZl 40.00 , 
G1'22 - 40. 00 • 
P16 1000.00 usee 
NOD 1 
TO 256 
srol 600.2028 MH: 
FIDRES 23.9353% Hz 
511 10 . 209 ppm 
FnNOOE Sta t es-1'PP1 
SI 1024 
SF 60 0. 2000000 MHz 
WOW QSINE 
sse 2 
LB 0.00 HlI: 
G' C 
PC 1.00 
S1 1024 
Me2 States -'l'PPI 
SF 600.2000000 MHz 
.,. 
SSB 
LB 
gSINE 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm ,B 
2 
0.00 H:: 
o 
! 
--\ 
I 
106 
ID-NOE s for syn-122 
SELNOGP 
I 
3.8 
SELNOGP 
3.8 
3.6 
3.6 
I 
3.4 
3.4 
3.2 
I 
3.2 
3.0 
3.0 
::g~:""CJJWO'" ~ .~R NM<EL><-J £XPliO SX7-02? ~:~NO II 
Time - 2009083i ~:~~~ 14.03 i~LPROG 5 fMI PABB~P:~: ~~LVENT "i~m 
DS CoeD 
SWH 1 6 !~D'ES 12019 23~ H 
RG l~j~~~~&~ H~ 
: 362.sec 
T£ 41.600 usee 
Dl 2~5 5~ usee 
DB 2 . 00000000 1'\ 
016 0 . 60000002 sec ~~~ g: ~~~; ~~~~ ::~ 
.o.._ 1 sec 
_ .. CHANN&L fl - IH-"'''· 
g.go usee 
80000 ' O~ usee 
120:00 ~ec 
O. OOO~~o~o dB :1.5.nB668~ : 
00.2012530 MHz 
GaUSl_18o;~i~~D dB 
0.500 
..... 0.00 H~ 
GP;;;'; GRADIENT CRANN 
GPNAH2 SIti£.l~ -=-=-~;----;;---;~--;;--"7:---r_J~ - :~:~~ SINE.lOO U, ' ,,. " .00 , .6 2.4 22 I I SI 10:g·gg • . 2.0 1 I ;~. , ••. 2O:~~i: um .8 ppm~~. EM HM, = 1_~_ 
I 
2.8 
I 
2.6 
1.00 
107 
ID-NOEs for anti-122 
SELNOGP 
ID,"III') .. 
","ocr. 
(D(Ocor---
,.;,.;,.;,.; 
\\// 
"'..,0000 
........... "'11'1 
11111'111') ...... 
'\V V 
'1fT 
N cr.II')N~~cr.~II')"''''''''''~N B~R 
L><..J 
NAME SX8-08JA 
EXPNQ 3 
fROCNO 1 
~ 11'1 MMMNN ...... OO~Il'I.MM 
<:) <:) OOOOOOOOOcr.I:O(oIDID 
~N.,·~.N.t .. ~N~~N~>~1i~~~·N~~~~NN~ 
Due 20091112 
Ticne- 9.07 
INSTRUM apeet 
PROSHO 5 11m TXI 1R/D-
POLPROG 5eln09P 
TD 32168 
SOLVENT eDelJ 
NS 16 
OS 2 
SlfH 12019.230 Hz 
FlORES 0 . 366798 Hz 
AQ 1.3632404 sec 
RG 128 
OW 4.1.600 usee 
DE 6.50 usee 
TE 295 . 2 K 
Dl 2 . 00000000 5eC 
D8 0.60000002 sec 
016 0 . 00020000 sec 
020 0.29879999 sec 
TOO 1 
_-i~.'Ir--'-··--"- CHANNEL fl ---- -NOel 
PI 
P2 
P12 
PL. 
PLI 
PLOW 
(lLIW 
Sro1 
SP2 
SPNAH2 
'POAL2 
SPOrrs2 
,. 
7.60 usee 
15. 20 Ilsee 
80000 . 00 usee 
120. 00 dB 
0.00 dB 
0.00000000 N 
12.55943203 W 
600.2012220 MHz 
66.71 dB 
GaUel_180~ : ~ggo 
0 .00 Hz 
--- GRADIE.tn' CHANNEL ....... 
GPNAMI SINE . 100 
GPNAK2 SINE . IOO 
GPZl 15.00 , 
GPZ2 40.00 , 
PHi lCOO.OO usee 
51 65536 
--__.---r_~-.._~-_,__~-...,-~_._--_.--__.--__,r_~-.._--_,__--_;;:~ 600.20000: MHz 
3.8 3.6 3.4 3.2 3.0 2.8 2,6 2.4 
SELNOGP 
2.2 2.0 1.8 ppm~B 0.3g Hz 
GS 0 
PC 1.00 
~.~Mm~~ ••• ~~ N~M~~~II~1I 
~~~~EEa~8~~~:~~~;g L><..J 
~~f/N(~~I'jjjj;j HA!"E ,. SX8-083A 
~ ~~ EXPNO ~ 4 
PROCNO ' 1 
Date 20091112 
Titlle- 9.09 
INSTRUM speet 
I1'ROBHO 5 mm TXI IH/O-
PULI?ROG se1noqp 
TO 32768 
SOLVENT CoeD 
NS 16 
OS 2 
SMl 12019.230 Hz 
FlORES 0 . 366798 Hz 
AQ 1. 363240"4 .sec 
RG 128 
OW 4.1.600 usee 
DE 6.50 usee 
TE 295.2 K 
01 2.00000000 sec 
08 0.60000002 sec 
016 0 . 00020000 sec 
020 0.29879999 sec 
TOO 1 
--- CHANNEL f1 - -----
NOCI 
01 
P2 
P12 
PLO 
OL1 
PLOK 
PLUi 
'E01 
SP2 
SPNAH2 
SPOAL2 
SPOFFS2 
IN 
7.60 usee 
15.20 usee 
80000.00 usee 
120,00 dB 
0.00 dB 
0.00000000 W 
12.55943203 W 
600.2010940 MHz 
66.71 dB 
Gaud l80r. I OOO 
- O.SOO 
0.00 Hz 
- -- GM.01EiNT CHANNEL --
GPNAH1 S INE. 100 
GPNAM2 SINE. 100 
GPZl 15.00 1 
GPZ2 40.00 I 
P16 1000.00 usee 
SI 65536 
~-.---...,-~--r----,-~-.._--_,__-~...,..--__.---... ~-.. -....:. ... ---ii~im tiOO . 20000~ MHz 
3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 ppm~~B o. 3g Hz 
GB • 
PC 1.00 
108 
I-D NOEs for 123 
SELNOGP 
Cft<.Qt"'INI"-OI")""'" 
." ... t")..., ..... I"IN..-I 
.... ,..,.."'''·10'''>1')",." 
~I~ ·BER N1.ME $Xl-08l EXPNO , PRQCNO 1 
=_ 2009::!~ 
INSTROH .pect 
PROBHD 5 nn '!"XI 1H/D-
PULPROG sel nogp 
TO 32168 
SOLVENT CDCl) 
HS 16 
DS , 
SIiH 12019.230 Hz 
FlORES 0.366798 fi:. 
AQ 1. 3632404 !lee 
RG 128 
OW 41.600 usee 
DE 6.50 usoe 
TE 295 .3 K 
D1 2.00000000 .ec 
08 0 . 60000002 sec 
OlD 0 .00020000 !lec 
020 0.29879999 sec 
TOO 1 
'---iIIr ..... jA".....--------- CAAttNiL :fl -_ ••••• 
HOCl 1M 
PI '1.60 ullec 
P2 15.20 usee 
P12 80000 .00 usec 
fLO 120.00 dB 
iLl 0.00 dB 
Pl.OW 0.00000000 • 
PLlW 12.55943203 • 
SFOI 600.2011.9"0 MH~ 
SP2 66.'11 dB 
~:~~~ G.1usl_UO~:~~go 
SfOFFS2 0.00 Hz 
.... _. GRADIENT CHANN&l,. ---
GI'NAHl SIm .100 
GPNAH2 SINE . 100 
GPZl 15.00 , 
GPZ;2 40.00 1: 
P16 1000.00 usee 
S1 65SJE 
--""r-'-~~--r----"'-:-. ---,----...;~~--_r----,_---,......;~~~ 600.20000~~ KHz 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm~B 0.,: K, 
G8 0 
PC 1.00 
a~R 
NAME sx7-0Bl 
~~~o (>.. i 
SELNOGP 
~~~~~~~~~~M~O~~ ~~~M~.~~mN~O~w~~M.~~~~ 
~~~~~:~~::~re~~~ ~~~~~~~~~~~~~~~~~~~~~~ 
~~~~~·~\V/~~~·t~~ .. ·7.iMw,7~~~j~;~--~ 
Date 20091109 
Tillle- 13.17 
INSTRUH "'pect 
PROSHO 5 1MI TXI lll/D-
PULPROG eelnogp 
TO 32769 
SOLVENT coeD 
NS 80 
DS 2 
SWH 12019 . 230 Hz 
FlORES 0.366198 Hz 
AQ 1 .3632404 uc 
RG 12B 
OW 41.600 usee 
DE 6.50 usee 
TE: 295.0 K 
D1 2.00000000 sec 
OS 0.60000002 see 
016 0.00020000 see 
020 0.298'19999 see 
TOO 1 
:~~i".-- CHANNEL tl -;=---
Pl 1.60 usee 
P2 15 . 20 usee 
__ --..fJ;pJ I"----J 
P12 80000 .00 usee 
PLO 120.00 dB 
PLI 0.00 dB 
PLOW 0.00000000 N 
PLlw 12.55943203 '" 
SFOI 600 . 2022477 MHz 
SP2 66.11 dB 
~::~ Gau.s1_180~:;g~0 
SPOFFS2 O. 00 H~ 
---- GRAD1ENT CHANNEL ---
GPNAMl SINE.IOO 
GfNAM2 SINE .100 
GPZl 1 ~. 00 , 
GPZ2 40.00 , 
PUi 1000.00 usec 
SI 65536 
---~"'--"':"':'--T---"'-:'-r~---"---""r-'~~--"-----r---~-'-I ~~ 600.20000~ MHt 
ppm~8 O. 3g Hz 
G8 0 
4.0 3.5 3.0 2.5 2.0 1.0 1.5 
~ 1.00 
109 
I-D NOEs for 122 
SELNOGP a~R 
~ SX7-087 
EXPNO "1 
PROCNO 1 
Date 2009t116 
Time- 1t . 59 
INSTRUH :lllpecl 
PROBIfO 5 In TlU 1M/I>-
PULPROG aelnoqp 
TD 32768 
SOLVENT CDClJ 
NS 16 
DS , 
SNtI 12019.230 Hz 
£lDRES 0.366798 Hz 
AD 1.3632404 sec 
RG 45.3 
.0\11 41.600 usee 
DE Ii.SO usee 
T£ 295.1 tc: 
D1 4.00000000 58C 
08 1.00000000 :IIec 
OUi 0.0002000(1 $Io!C 
020 0.49880001 aec 
tOO 1 
.,_-----' '!'--!" ........ ....m'"IIr'..,..--------'\I'i'"--. __ .. __ CHANNEl f 1 ----
NUCI 
" 
" 
'" PL' 
PLl 
PLO. 
PLIN 
SFOI 
SP' 
SptlAM2 
SFOAL' 
SPOFFS2 
IH 
7.60 usee 
15 .20 usee 
eoooo.OO uaee 
120. 00 d8 
0.00 dB 
0.00000000 " 
12 . 55943203 " 
600.2016097 HHz 
66.71 dB 
Gausl 180r.lOOO 
- 0 • .500 
0.00 Kl. 
... _- GAAOI£NT CHANNEL ----
GPNAHl SZNE.IDO 
GPNAH2 SINE. 100 
GI'U 15. 00 , 
GP.22 40. 00 , 
1'16 1000.00 usee 
51 65536 
~-----,----......,--...;..:-.,_---__,_---__r----.,.---_,_---__,,-....;:~ 600.20000~~ MHz 
3.5 3.0 2.5 2.0 1.5 1.0 0.5 
SELNOGP 
ppm~~B O. 3~ Hz 
GB , 
PC 1.00 
a~R 
LX-J 
NAK£ "" SX7-0B7 
EXI?NO 7 
PROCNO 1 
Date 20091116 
Tim&- 14.59 
lNSTftUM speet 
PROBHD 5"," TXl IH/D-
PULPROG selnogp 
TD 32168 
SOLVENT CDC13 
NS 16 
OS , 
SWH 12019.230 Hz 
nDMS 0.366198 Hz 
1.0 1 .3632404 sec 
RG 45.3 
ow 41.600 usee 
DE 6.50 usee 
IE 295.1 K 
Dl 4 . 00000000 sec 
DB 1.00000000 see 
D16 0.00020000 see 
020 0.049880001 see 
TOO 1 
_____ CHANNEL f1 ------
NOCl 
PI 
P2 
PI2 
>L' OLl 
PLOW 
PL1. 
SFaI 
SP' 
SPN/IJo'.2 
SPOAL2 
SPOFFS2 
I. 
7.160 usee 
15.20 usee 
eoooo.OO usee 
120.00 dB 
0.00 dB 
0.00000000 W 
12.559432.03. 
600.2016097 MHz 
66.71 dB 
Gausl nOr .1000 
- 0.500 
0.00 Hz 
- --- GAADIENT CHANNEL --
GPNAAI SINE.lOO 
GPN1\M2 SINE.lOO 
GPZl 15.00 , 
GPZ2 40.00 , 
fa 1000.00 u see 
81 65536 
--,.-.,..-,....-r,-..,..-.,.........,-...,..-...... "";''''';'"''I''-'''''''-'''''-''-'''''-''--'-'''''-'''''''""I-'''''' -W!'~ 600.20000: MHz 
3.6 3.5 3.4 3.3 3.2 3.1 3.0 2.9 2.8 2.7 2.6 2.5 2.4 2.3 2.2 2.1 2.0 1.9 1.8 1.7 ppm~· ,.,g "' 
GB , 
PC 1.00 
110 
0 
~~~ '" ,",0 -... "! on on ~C!: """! CD ""CD ai on '"' oon 
T "" .... 
on ....
.,'" \\I I \ I I I 
0-l 
NIiN-.t-Bu 
N'Bn 
141 
" 
b". : :.UU ' ..... · i' Irll'lK 
I 
180 160 140 120 100 80 60 40 20 
.~R 
L;><.....J 
"-
ax4-IiSS 
EXPNO 2 
PF;OCEO 1 
Dat.._ 2009011 i 
Ti .... l L03 
JI:SIRtlM Gp5'ct 
''0208D 5 Q PU:!O Ie-
PULP~':;; ~~1~~ tl) 
~OLVfJU ct)\711 
Mil Z~" 
D:: • 5W. lSPH.2H n2 
F:DAES 1. r;g.'iSS Hz 
AQ C. .4S: -!3H uc 
RG 1<146.2 
.x l~ .SGO un·c 
•• oE .Oeo us.c IE 295.4 r; 
., 2 .000CCCoGO nc 
dB 0.02(01)000 :icc 
DELtA 1 . e999999B nee 
Tl)O 1 
---- C~NnEL f l ----!tl)::l He 
., a.co \lUC: 
.. I -l.CO -em 
SFOl lSO . P3H·021 ~% 
---- C Ki\~"H!;L f2 ----
CPDP~)2 waltz.16 
NI)C2 I . 
PCPD2 7C' . CO 1J!i~C 
.1.2 -4.00 d!! 
PL12 11.Ci ~ 
'Ltl l. ! .OO $ 
sro2 '00 .2024008 HI: 
$1 ~11eE: 
5. 1!O.92C4!.CO t!H: 
"".. W-
••• 0 to 1. &(. Hz. 
•• • PC 1. 40 
ppm 
.~R 
~ n4-0S5 
EXFMO 1 
Pli:OCt;O 1 
Qat.__ 200BO l!.. i 
tin- H.CO 
Is~rRU"J s~ct 
PF.'O!HO S Q PA&IO 2&-
~ULP.w.. 3~li~ 
~OLVDn 
"' . , OW" 
f'%DRE~ 
AQ 
RG 
.w 
.E 
t. 
., 
toO 
CDCU 
4 
• 12~H.227 Hz. 
0.3'71693 Hz. 
1.:2;-9116 nc: 
1<1.; 
.0.400 uno: 
':.00 une: 
295.1 K 
1.00000000 ne 
I 
---- CHA.."'UEL fl ----
Nt.'Cl 1H 
P! 11.00 uuc 
PLl -t.OO ~ 
srOl 600 .20 HOES v.H: 
S! ~21€e 
Sf' 600 . 20(10 146 t'!H2: 
we-X" EY. 
5S! C! 
L! O.~G H: 
.. ! " PC 1 .0 0 
______ .1...--__ --' '-'-_--'~VI.WI..J'__ __ ....JI" vl_.L ..... J ,.......... __ 
9 8 7 2 ppm 
~1~1 1~1 
111 
!11;;; ;t:~ t- ~m a~R ~~ cSlci ;;j clcl IT t- "'''' V I V L><.J 
,I :9 .""" IX7-00:!cryoE-t.l-c: EXPliO 1 6~d-C) '" I PROCt:O 1 Dn._ 20-0500729 Tn-. 1.9.59 Jt:S'tRUM S'pe.ct 
I ~ 'cr~ PRQ2HD S r:=I PA5!1O l!5-PULPr.o .. ~'ID~~ TO ~OLVEnt CDcll 
~ / "- 9~ 256 os 0 
OllB 119B5.61.1 Hz. 
145 FID1t!::, 0. 54$871 Hz. AQ O.91l00(l.4 ue 
PoG 25110. J 
O~ 21.BGG une 
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